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ABSTRACT

AUTOTAXIN: A REGULATOR OF OLIGODENDROCYTE DIFFERENTIATION
By Larra W. Yuelling
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2010
Advisor: Babette Fuss, Ph.D., Professor, Department of Anatomy and
Neurobiology
In order for oligodendrocyte progenitor cells (OPCs) to differentiate into
fully mature, myelinating oligodendrocytes, they must be specified at the correct
times and undergo coordinated changes in both gene expression and
morphology. As oligodendrocytes differentiate, they transition from a bipolar
morphology into a morphology characterized by a complex network of multiple
processes, which will eventually generate membranous structures necessary for
myelination of axonal segments. As changes are observed in cellular
morphology, oligodendrocytes also undergo changes in their gene expression
profile and express genes necessary for both early and later stages of
development such as olig1 and myelin basic protein (mbp), respectively.
Data from our laboratory demonstrate that autotaxin (ATX), also referred
to as phosphodiesterase Iα/autotaxin (PD-Iα/ATX), is involved in all of these
processes as a multifunctional protein by regulating lysophospholipid signaling

x
and cell-extracellular matrix interactions. Previously, our laboratory has identified
ATX as an oligodendrocyte-secreted factor present in the extracellular
environment that via a newly-identified functional domain, named the MORFO
domain (modulator of oligodendrocyte remodeling and focal adhesion
organization), can regulate adhesion of oligodendrocytes to naturally occurring
extracellular matrix (ECM) proteins and ultimately the establishment of the
oligodendrocyte’s complex process network. In vitro data presented in this
dissertation suggest that lysophosphatidic acid (LPA), via production from ATX’s
well characterized lysophospholipase D (lysoPLD) domain, can induce the
expression of myelin basic protein (mbp) and the establishment of membranous
structures by differentiating oligodendrocytes, both necessary for the initial
stages of myelination. Interested in relating these functions to an in vivo model
and due to the early embryonic lethality of atx-null mice, we utilized the zebrafish
as an in vivo model. The in vivo data presented in this dissertation demonstrate
that atx expression in the zebrafish is evolutionarily conserved within vertebrates.
Interestingly, in both mouse and the zebrafish, atx was found expressed by cells
of the cephalic floor plate in addition to differentiating oligodendrocytes.
Functionally the in vivo data presented in this dissertation confirmed ATX’s role in
stimulating mbp expression during later stages of oligodendrocyte development.
In addition, a novel function for ATX was revealed by the studies undertaken as
part of this dissertation that has never been described before. More specifically,
based on the timing of atx expression and the phenotype seen upon atx knockdown, the data presented here suggest that ATX, released by the cephalic floor

xi
plate, regulates early oligodendrocyte development and/or specification. Taken
together, these data identify ATX as a major regulator for early as well as late
developmental stages of the oligodendrocyte lineage.

CHAPTER 1
Introduction to Oligodendrocyte Biology and Autotaxin
(The section of this chapter describing autotaxin includes parts of a review that
was accepted in Biochimica et Biophysica Acta (BBA) - Molecular and Cell
Biology of Lipids in April of 2008. The review was written by myself with
guidance from Babette Fuss.)
Myelination and its biological significance
In mammals, myelination takes place in late embryonic and early postnatal
life by oligodendrocytes, the myelinating cells of the central nervous system.
Once mature, these cells produce the myelin sheath, a lipid rich multilamellar
membrane that surrounds and insulates axons allowing for fast conduction of
electrical impulses, called action potentials, over long distances. Action
potentials are required for the nervous system to function efficiently.
The generation of the myelin sheath is an evolutionary adaptation
common to the majority of vertebrates (Schweigreiter et al., 2006; Hartline and
Colman, 2007). Without it, faster conduction speeds are attained through
increased axon diameter (i.e. the squid giant axon). The myelin sheath
conserves space by allowing axons of small caliber to communicate quickly over
long distances (Hartline and Colman, 2007). The unmyelinated squid giant axon
occupies 15,000 times more space than a myelinated mammalian axon with a
comparable conduction speed (Salzer, 1997).
The myelin sheath is distributed along the axon in long segments called
internodes, with intermittent gaps in between called the nodes of Ranvier.
Sodium channels cluster at the nodes and increase conduction speed by
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allowing action potentials to “jump” from node to node, a process referred to as
saltatory conduction (Salzer, 1997). Myelin is crucial for saltatory conduction
because it provides long-term maintenance of the nodal domain which contains
sodium channels (Salzer, 1997; Dupree et al., 2004). Myelin also increases
conduction speed by preventing the electrical current from dissipating through
the insulation of the axon. This increases the electrical resistance across the cell
membrane and decreases capacitance. Each oligodendrocyte can myelinate up
to 40 internodal segments on multiple axons (Pfeiffer et al., 1993).
Along with promoting fast signal propagation, myelin has been shown to
be important in maintenance of axonal integrity (Griffiths et al., 1998b; Nave and
Trapp, 2008). The myelin sheath produced by oligodendrocytes is therefore
crucial for proper signal conduction in the central nervous system. If
oligodendrocytes are damaged or not present, the resulting signal disruption can
lead to a wide range of disability as seen in disease.

Diseases affecting myelin
Diseases affecting myelin include dys-myelinating diseases such as
leukodystrophies, hereditary neurodegenerative disorders when myelin is not
produced, or acquired demyelinating diseases such as multiple sclerosis (MS),
where myelin was present but has been damaged.
MS is the most common demyelinating disease and is usually seen in
patients ranging from 20 to 50 years old. Current estimates are that
approximately 2.1 million people worldwide have MS, with 400,000 cases in the
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United States (Multiple Sclerosis Society, 2010). MS is the leading cause of
nontraumatic disability and symptoms, although unpredictable and can vary from
person to person, encompass sensory and motor abnormalities, visual difficulties
and cognitive dysfunction (Fox et al., 2006).
MS is classified according to different courses of the disease: relapsingremitting, primary progressive, secondary progressive and progressive-relapsing.
Patients start the disease course as either having relapsing-remitting MS (85% of
patients) or primary progressive MS (10-15% of patients). In relapsing-remitting
MS, episodes of inflammation, called relapses, are accompanied by the
introduction of new symptoms or resurfacing of old symptoms. Relapses can last
several days to weeks followed by remission which leads to partial or full
recovery and can take up to weeks or months to occur. In between relapses the
disease does not get worse, but either shortly after being diagnosed with, or up
to 10-20 years of having relapsing-remitting MS, conditions gradually get worse
and the disease transitions into secondary progressive MS. There may be some
relapses in the begininning of this stage but conditions continue to get worse in
between leading to a steady decline with no recovery (Lublin and Reingold, 1996;
Fox et al., 2006).
As stated above, some patients alternately start the disease course with
primary progressive MS characterized by gradual worsening of symptoms with
no relapses or remissions, similar to secondary progressive MS. It is thought that
some patients in this group initially started with relapsing-remitting MS but either
the areas of inflammation did not target white matter to cause symptoms or the

3

relapses were not recognized or remembered by the patients (Lublin and
Reingold, 1996; Fox et al., 2006).
The least common form of MS is progressive-relapsing MS and usually,
but not always, occurs in patients that initially had primary progressive MS. This
course of the disease is characterized by acute attacks that may or may not have
recovery associated with them (Multiple Sclerosis Society, 2010).
Because there are different disease courses that present themselves in
MS, different patients may experience different courses of the disease. Also,
each patient will likely experience more than one disease course through their
life.
In MS lesions, remyelination occurs with great efficiency, especially early
in the disease but frequently fails in chronic lesions leading to persistent
demyelination. The pathogenesis of MS is still not completely understood and in
order to gain an understanding about the process of myelination it is important to
understand the cellular biology and development of the oligodendrocyte.

Oligodendrocyte specification
Oligodendrocytes are found distributed throughout the adult brain and
spinal cord, accumulating mainly after birth in rodents but their progenitors are
present much earlier in restricted locations in the central nervous system (Warf et
al., 1991; Noll and Miller, 1993; Pringle and Richardson, 1993; Pringle et al.,
1998).
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The majority of research looking at oligodendrocyte specification and
development has been conducted on ventrally derived oligodendrocytes in the
rodent spinal cord. In the spinal cord, oligodendrocyte progenitor cells (OPCs)
are specified from neuroepithelial precursors in a restricted domain of the ventral
ventricular zone termed the motor neuron progenitor domain that also generates
motor neurons (Warf et al., 1991; Noll and Miller, 1993; Fu et al., 2002). This
domain is located immediately dorsal to the ventral midline structure termed the
floor plate. OPCs are first identified in the cervical spinal cord of the rat on
embryonic day 14, while motor neurons have been identified a few days earlier,
between embryonic days 11-13 (Yu et al., 1994; Pringle et al., 1996). Please
refer to more detailed descriptions of oligodendrocyte specification and early
development in chapter three.
Oligodendrogenesis in the brain has not been studied as extensively as in
the spinal cord. Oligodendrocyte development and myelination occurs in a caudal
to rostral pattern, occurring earlier in the spinal cord than in the brain and
subsequently earlier in caudal versus rostral regions of the brain. OPCs appear
postnatally in both the ventricular and subventricular zones lining the ventricles of
the brain and more specifically, they are generated from the subventricular zone
of the lateral and fourth ventricles in the rat cerebrum and cerebellum,
respectively (Reynolds and Wilkin, 1988, 1991; Levison and Goldman, 1993). As
in the spinal cord, oligodendrocytes in the hindbrain and midbrain are generated
from ventral ventricular zone precursors (Ono et al., 1997; Alberta et al., 2001;
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Davies and Miller, 2001; Nery et al., 2001; Tekki-Kessaris et al., 2001; Lu et al.,
2002; Zhou and Anderson, 2002).
There has been some debate through the years on whether
oligodendrocytes are solely generated in ventral locations as initial chick-quail
chimera experiments conducted in the spinal cord indicated dorsally derived
oligodendrocytes at later stages (Cameron-Curry and Le Douarin, 1995). These
studies were not confirmed until recently with further evidence pointing towards a
later, dorsal origin in the hindbrain and spinal cord (Cai et al., 2005; Fogarty et
al., 2005; Vallstedt et al., 2005; Richardson et al., 2006). One critical study in the
forebrain of mice not only discovered different populations of oligodendrocytes
generated from multiple locations induced at various times, but that these
populations are able to spread and populate areas where one population was
destroyed (Kessaris et al., 2006).

Oligodendrocyte development and differentiation
After OPCs are specified in the ventricular and subventricular zones, they
migrate away from these zones and proliferate extensively to populate the brain
and spinal cord where they ultimately differentiate into myelinating
oligodendrocytes. Throughout their development, oligodendrocytes are
characterized by the sequential expression of developmental markers (lipids,
proteins and surface antigens). Presence of these markers as well as changes in
cellular morphology have made it possible to identify different stages of the
oligodendrocyte lineage (Pfeiffer et al., 1993).
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OPCs are migratory and proliferative cells with a bipolar morphology.
Once they are specified, they proliferate in the rat brain from a population of ~5 x
105 at birth to ~60x 106 cells in the adult and as they proliferate, they migrate
throughout the central nervous system to their proper locations (Pfeiffer et al.,
1993). The majority of proliferation occurs after they leave the ventricular and
subventricular zones (Miller et al., 1997). In the rodent system, many OPCs can
be identified via the expression of gangliosides recognized by the A2B5 antibody
(Eisenbarth et al., 1979; Raff et al., 1984) and by expression of the α-receptor for
platelet-derived growth factor (PDGFαR) (Fig. 1.1) (Hart et al., 1989b; Pringle et
al., 1992; Ellison and de Vellis, 1994). The ability of OPCs to proliferate is
dependent on extrinsic cues whereby activation of the PDGFαR by PDGF
enhances the proliferation and survival of OPCs (Noble et al., 1988; Hart et al.,
1989a). Fibroblast growth factor (FGF2) is also mitogenic and upregulates
PDGFαR expression in OPCs and blocks their differentiation into
oligodendrocytes (Bogler et al., 1990; McKinnon et al., 1990).
The transition from an OPC to a mature differentiated oligodendrocyte is a
critical step during development. As oligodendrocytes begin to differentiate, they
develop more processes and become multipolar. They can be identified by
expressing an unidentified antigen, POA (pro-oligo antigen), on their surface
recognized by the O4 monoclonal antibody (Fig. 1.1) (Sommer and Schachner,
1981; Bansal et al., 1992). This is the last stage where the cells have significant
proliferative capabilities and the first stage where they become post-migratory
(Warrington and Pfeiffer, 1992). Soon after onset of recognition of the O4
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antibody with POA, reactivity to the A2B5 antibody disappears as well as
proliferative responses to PDGF (Hardy and Reynolds, 1991; Pfeiffer et al.,
1993).
Lineage progression then continues to the immature oligodendrocyte
stage where the cells are post-migratory, only migrating short distances if
needed, and still retain some proliferative capacity. These more mature cells
express markers of differentiation such as 2,3 cyclic nucleotide-3phosphodiesterase (CNP), sulfatide and galactocerebroside (GalC) (Fig. 1.1)
(Pfeiffer et al., 1993). CNP is a myelin protein that catalyzes the hydrolysis of
2’,3’-cyclic nucleotides to produce 2’-nucleotides (Wells and Sprinkle, 1981;
Sprinkle et al., 1983; Kim et al., 1984; Sprinkle, 1989). It is confined to
oligodendrocytes in noncompact regions of the myelin sheath (Braun et al., 1988)
and has high binding affinity for cytoskeleton proteins and was recently shown to
regulate branching and process formation of oligodendrocytes (Lee et al., 2005).
Sulfatide and GalC are sphingolipids highly enriched in myelin and are
recognized by the O4 and O1 monoclonal antibodies, respectively, on their cell
surfaces (Fig. 1.1) (Bansal et al., 1989; Warrington and Pfeiffer, 1992).
Mature oligodendrocytes are postmitotic, terminally differentiating cells
that express late myelin proteins such as myelin basic protein (MBP), proteopilid
protein (PLP), myelin-associated glycoprotein (MAG) and myelin-oligodendrocyte
glycoprotein (MOG) as well as maintain continued expression of sulfatide, GalC
and CNP (Fig. 1.1). Expression of genes encoding the more mature proteins is
followed by synthesis of myelin-specific lipids and elaboration of the myelin
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sheath by oligodendrocytes (Pfeiffer et al., 1993). Myelination is a process that is
developmentally regulated as it requires coordination of the above-described
lipids and myelin proteins (Campagnoni and Macklin, 1988).
MBPs are a class of myelin proteins expressed by oligodendrocytes in the
central nervous system. They are abundant in myelin, representing 30% of total
myelin protein, are membrane associated and important for fusion (compaction)
of the opposing cytoplasmic membranes of myelin (Omlin et al., 1982; Readhead
et al., 1990). In the shiverer mutant mouse where a large portion of the mbp gene
has been deleted, oligodendrocytes begin to myelinate but cannot form
compacted myelin in the central nervous system (Readhead et al., 1990).
The mbp gene, first identified in the mouse, contains seven exons which,
through alternative splicing of exons 2 and 6, account for the four major “classic”
MBP variants which have different molecular weights (14kDa, 17kDa, 18.5kDa,
and 21.5kDa) (Barbarese et al., 1977; Yu and Campagnoni, 1982; de Ferra et al.,
1985; Takahashi et al., 1985). A few years later, a third exon (exon 5), was found
to also be differentially spliced out in the processing of the mouse MBP gene
transcript creating a second 17kDa isoform (Newman et al., 1987). During this
time there was evidence that more molecular forms exist (Greenfield et al., 1982;
Sorg et al., 1986) and due to the newer discovery of an unidentified “exon 5a” it
is now known that there are at least seven transcripts expressed (Aruga et al.,
1991).
The splicing of the classic mbp transcripts is developmentally regulated in
oligodendrocytes (Campagnoni et al., 1978; Carson et al., 1983; Campagnoni,

9

1988). Transcripts containing exon 2 (21.5 and 17kDa isoforms) are expressed at
high levels early during myelination then decline with development (Barbarese et
al., 1978; Campagnoni, 1988) while the more mature isoforms (14 and 18.5kDa)
are expressed later and are incorporated into the myelin sheath (Newman et al.,
1987; Jordan et al., 1990).
As well as being expressed during developmental myelination, exon 2containing mbp transcripts are also expressed in oligodendrocytes during
remyelination as they react to demyelination with widespread mbp mRNA
synthesis (Kristensson et al., 1986) as seen in lesions of a demyelinating animal
model and during remyelination in adult mice after viral depletion of
oligodendrocytes (Jordan et al., 1990; Nagasato et al., 1997).
Differing from other myelin protein mRNAs such as plp (Trapp et al.,
1987), mRNAs for mbp have to be transported through oligodendrocyte
processes to intracellular regions and translated locally where myelin compaction
occurs because their proteins are highly charged and have a strong affinity for
membranes (Campagnoni et al., 1980; Colman et al., 1982; Kristensson et al.,
1986; Verity and Campagnoni, 1988). The transport of mbp mRNA requires a
RNA transport signal in the 3' untranslated region and localization of mRNA to
the myelin compartment requires an additional element, the RNA localization
region (Ainger et al., 1997).
Proteolipid protein (PLP) is a membrane spanning protein that constitutes
about 50% of the protein in the myelin sheath. PLP consists of four hydrophobic
transmembrane domains on the outer membranes of myelin (Popot et al., 1991;
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Nave, 2001) and although it is an abundant protein in myelin, its function has
been mainly attributed to axonal survival. Initially, the function of PLP was
thought to be directly associated with myelin sheath deficits because of
observations in PLP mutant mice. The jimpy mutation was the first mutation
identified in the plp gene and mice harboring this mutation lack the majority of
central nervous system-specific myelin due to the absence of mature
oligodendrocytes because of cell death. The little myelin that remains has
ultrastructural abnormalities as would be expected for an integral myelin protein
(Meier and Bischoff, 1974, 1975; Duncan et al., 1989; Skoff, 1995). It was later
unexpectedly discovered that plp-null mice, in which the plp gene is inactivated,
display no myelin abnormalities or oligodendrocyte loss, but develop axonal
degeneration and so it then was suggested that the observations in the PLP
mutant mice were a result from misfolded protein responses (Griffiths et al.,
1998a; Griffiths et al., 1998b).
PLP has a splice variant that it is co-expressed with named DM20 which
differs by a 35-amino acid deletion in exon 3B of the gene (Agrawal et al., 1972;
Trifilieff et al., 1986; Macklin et al., 1987; Nave et al., 1987). The splicing of the
PLP/DM20 gene is developmentally regulated and the appearance of DM20
precedes PLP in many species (Yu et al., 1994; Dickinson et al., 1996; Spassky
et al., 1998). As development proceeds, expression of DM20 declines as PLP
increases (Griffiths et al., 1998a) and during these later stages of development
DM20 protein has been identified in compacted myelin (Nave, 2001).
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The myelin membrane is also composed of other proteins beside MBP
and PLP, such as myelin oligodendrocyte glycoprotein (MOG). MOG is a minor
membrane protein composing 0.1% of total protein and is found on the surface of
oligodendrocytes. It is the last myelin protein expressed and is a marker for
mature oligodendrocytes (Kettenmann and Ransom, 2005). The function of MOG
is not yet known but it has been suggested to function in the myelin sheath and
not during development (Roth et al., 1995).
.
The oligodendrocyte cytoskeleton
Along with the expression of various lipids and proteins during
oligodendrocyte differentiation, cell shape changes also occur and are mediated
by the cytoskeleton. The cytoskeleton of oligodendrocytes is composed of
microtubules and microfilaments and devoid on intermediate filaments (Wilson
and Brophy, 1989).
In less mature, younger oligodendrocytes, microfilaments are much more
abundant than microtubules, and are found in many processes emerging from
the cell where they mediate process outgrowth resulting in the formation of
filapodia and lamellopodia (Wilson and Brophy, 1989). Alternately, microtubules
serve as mechanical stability for processes in more mature oligodendrocytes and
are present in the cell body and primary processes, not at the distal tips (Lunn et
al., 1997; Song et al., 2001; Bauer et al., 2009).
Microtubules are made of subunits of α-tubulin and β-tubulin which
assemble as heterodimers and form a hollow cylindrical shape. In order to
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promote stability of oligodendrocyte processes as seen in more mature
oligodendrocytes, tubulin subunits must undergo posttranslational modifications
including acetylation of α-tubulin (Song et al., 2001). Acetylation of α-tubulin is
important for maintaining the complex process arborization necessary for proper
morphological differentiation. As oligodendrocytes mature, they generate larger
processes and membranous structures. These membranous structures are
mainly devoid of tubulin but have a few, large acetylated α-tubulin-containing
processes that extend throughout the structure (Richter-Landsberg, 2000).
In order for oligodendrocytes to develop in a proper, timely manner they
must not only express the correct genetic profile, but it is also crucial that process
morphology is regulated correctly. It is still debated whether gene expression is
directly linked to cyoskeletal development or if the two processes can be
uncoupled, but regardless of the mechanism, it is necessary that both processes
function together at the correct time to develop functional myelinating
oligodendrocytes.

Oligodendrocytes and remyelination
It is of interest to note that not all OPCs differentiate during development
as they are present in the adult CNS. These cells still have proliferative
capabilities (Wolswijk and Noble, 1989; Wolswijk et al., 1991) and have been
shown to respond to demyelination by increasing in numbers and repopulating
the lesion site (Reynolds et al., 2001).
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Either due to the presence of these OPCs or from OPCs recruited from
the subventricular zone, MS patients have extensive spontaneous remyelination
in early phases of the disease, occurring more than previously thought, but
eventually remyelination will fail as the disease progresses (Patani et al., 2007).
OPC recruitment and differentiation are both very important for
remyelination to occur. Studies in older animals have suggested that even
though both processes are not as efficient, failure of differentiation of OPCs and
not recruitment may be the reason for limited remyelination (Sim et al., 2002;
Woodruff et al., 2004; Shen et al., 2008). In agreement with these studies, it has
been reported that MS lesions contain substantial numbers of OPCs with no
evidence of remyelination (Wolswijk, 1998; Chang et al., 2000; Chang et al.,
2002; Wolswijk, 2002; Kuhlmann et al., 2008). Even though OPCs are present
and recruited in MS lesions initially, over time they do become depleted
(Kuhlmann et al., 2008) which could be the reason behind progressive stages of
MS. In the case where there are large areas of demyelination, OPC recruitment
may not be efficient enough to repopulate the whole area and so experimental
studies have found that transplanted OPCs could repopulate those areas with
much greater efficiency than endogenous OPCs (Chari and Blakemore, 2002).
Limited remyelination in MS lesions suggests that myelination is possible
but needs to be stimulated (Armstrong, 2007). One such molecule that can
stimulate oligodendrocyte differentiation is the oligodendrocyte-secreted protein
autotaxin (ATX) (Fuss et al., 1997; Fox et al., 2003; Dennis et al., 2005; Dennis
et al., 2008; Yuelling and Fuss, 2008; Nogaroli et al., 2009). Atx expression is
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reduced in MS lesions (Comabella and Martin, 2007) and could be a potential
target for treatment.

Autotaxin
Autotaxin (ATX), also designated phosphodiesterase Iα/autotaxin (PDIα/ATX) or (ecto)nucleotide pyrophosphatase/phosphodiesterase 2 [(E)NPP2],
was originally discovered as an autocrine motility stimulating factor released by
human melanoma cells (Stracke et al., 1992). This functional property was the
foundation for its name autotaxin, which remains the most commonly used
designation. cDNA cloning identified a brain-specific alternatively spliced isoform
that based on the protein's enzymatic phosphodiesterase activity was designated
phosphodiesterase Iα (PD-Iα) (Narita et al., 1994; Kawagoe et al., 1995).
Possessing enzymatic activity, ATX was subsequently included in the family of
nucleotide pyrophosphatase/phosphodiesterase (NPP)-type
ectophosphodiesterases and additionally termed (E)NPP2 (Bollen et al., 2000;
Goding et al., 2003; Stefan et al., 2005). To date, at least three splice
variants/isoforms of ATX have been identified in both human and mouse, and
they have been recently referred to as autotaxin α, β and γ, with autotaxin γ
being identical to PD-Iα (Murata et al., 1994; Lee et al., 1996b; Kawagoe et al.,
1997; Giganti et al., 2008). The known isoforms of ATX display characteristic
expression patterns but do not appear to exert major differences in the substrate
specificity of the enzymatically active site, and to our knowledge, no major
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functional isoform differences have been identified so far (Lee et al., 1996b; Fuss
et al., 1997; Giganti et al., 2008).
ATX has been found to be released by a large variety of tumor cells and to
be expressed within a number of different tissues during normal development
and in the adult (Narita et al., 1994; Kawagoe et al., 1995; Lee et al., 1996b;
Fuss et al., 1997; Bachner et al., 1999; Ohuchi et al., 2007; Savaskan et al.,
2007; Giganti et al., 2008). Furthermore, high protein levels of ATX have been
observed in biological fluids, i.e. plasma and cerebrospinal fluid (CSF)
(Tokumura et al., 2002; Umezu-Goto et al., 2002; Sato et al., 2005). Despite this
rather broad expression pattern, a major focus in the research related to ATX has
long remained in tumor cell biology.
More recently, ATX has gained new attention since it was discovered to
act as the major extracellular enzyme generating the bioactive lipid signaling
molecule lysophosphatidic acid (LPA) , i.e. as an extracellular lysophospholipase
D (lysoPLD) (Tanaka et al., 2006; van Meeteren et al., 2006). In addition, current
studies investigating ATX's role during CNS development uncovered a novel
functionally active site and thus highlighted a multi-functional and multi-modular
nature of ATX (Fox et al., 2003; Fox et al., 2004; Dennis et al., 2005; Dennis et
al., 2008).
The first mentioning of ATX in the literature dates to the early 1990s, when
it was discovered as part of a search for active cellular motility stimulating factors
involved in tumor cell invasion (Stracke et al., 1992; Stracke et al., 1993).
Isolation of a cDNA encoding this 125 kDa glycoprotein and subsequent
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sequencing revealed that ATX did not exhibit any significant homologies to
previously characterized motility and growth factors. However, ATX was found to
contain a domain that displayed high homology with the enzymatically active
domain of proteins known to possess nucleotide phosphodiesterase and
pyrophosphatase activity, in particular bovine intestinal 5′ nucleotide
phosphodiesterase and plasma cell glycoprotein-1 (PC-1) (Culp et al., 1985; van
Driel and Goding, 1987; Buckley et al., 1990; Murata et al., 1994). Furthermore, it
was found that the homology between ATX and PC-1 was not restricted to the
enzymatically active site but extended through the entire length of their
extracellular portions. Thus, both proteins shared additional properties and
domains, namely two adjacent somatomedin B-like domains, a nuclease-like
domain and a single EF hand-like motif (Fig. 1.2). Due to the homology to PC-1,
ATX's N-terminus was originally thought to represent a transmembrane region
thus rendering ATX a type II transmembrane protein. However, it is now clear
that ATX is synthesized as a pre-pro-enzyme and secreted upon removal of the
N-terminal signal peptide and further trimming by a furin-type protease (Jansen
et al., 2005; van Meeteren et al., 2005; Koike et al., 2006; Pradere et al., 2007).
In the years following ATX's first cDNA isolation and sequencing, proteins with
similar structure–function domains were identified, leading to the creation of a
novel protein family, namely the (E)NPP family, which currently consists of seven
known members (Goding et al., 1998; Zimmermann, 1999; Bollen et al., 2000;
Goding et al., 2003; Stefan et al., 2005).
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Shortly after ATX's sequence had been identified, Lee et al.(Lee et al.,
1996) by using mutant recombinant forms of ATX, discovered that the catalytic
domain is crucial for motility stimulation. This finding prompted a more detailed
characterization of the catalytic activity of ATX and its relationship to the catalytic
activities of the other (E)NPP family members. Early studies showed that all
(E)NPPs hydrolyze both pyrophosphate and phosphodiester bonds present in
nucleotides and their derivatives (Bollen et al., 2000). However, their actual
physiological substrates still remained unidentified. It was later found out that
even though (E)NPPs have a structurally related catalytic domain, they differ in
their enzymatic substrate specificities (Gijsbers et al., 2001; Cimpean et al.,
2004; Stefan et al., 2005).
With regard to ATX, an important clue for its most likely physiological
substrate came from research related to the lipid signaling molecule LPA. The
discovery of an extracellular enzyme catalyzing the conversion from LPC to LPA,
i.e. an extracellular lysoPLD, revealed that ATX is molecularly identical to this
extracellular lysoPLD (Tokumura et al., 2002; Umezu-Goto et al., 2002; Ferry et
al., 2003; Xie and Meier, 2004). Moreover, ATX's affinity for LPC was found to be
significantly higher than its affinity for nucleotides (Tokumura et al., 2002;
Umezu-Goto et al., 2002). This finding that ATX may exert various biological
effects through its lysoPLD activity clearly marked a turning point in research
related to ATX (Moolenaar, 2002).
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ATX: enzymatic activity via the catalytic lysoPLD active site
Once the molecular identity of ATX as a lysoPLD had been identified, the
characterization of ATX's enzymatic activities was revisited. ATX's NPP activity
had long been known to be dependent on a single threonine residue located
within the catalytic domain (Clair et al., 1997). Mutational analyses showed that
the same residue is critical for ATX's lysoPLD activity and that lysoPLD activity
shares a common reaction mechanism with the originally described 5′-nucleotide
phosphodiesterase activity (Gijsbers et al., 2003; Koh et al., 2003). However, the
lysoPLD activity appears unique to ATX within the (E)NPP protein family, and it
seems to require in addition to the critical threonine residue, sequences within
the N- and C-terminal domains of ATX (Gijsbers et al., 2003; Cimpean et al.,
2004; Stefan et al., 2005). It was then proposed that the substrate specificity of
ATX's lysoPLD activity extends to the phosphosphingolipid sphingosine
phosphorylcholine (SPC), thus suggesting that ATX not only generates LPA but
also sphingosine 1-phosphate (S1P) (Clair et al., 2003). While this ability of ATX
has been well demonstrated in vitro, its physiological relevance still needs to be
demonstrated (van Meeteren and Moolenaar, 2007). ATX's lysoPLD products,
LPA and S1P, inhibit enzymatic activity at biologically relevant concentrations
(van Meeteren et al., 2005). This was discovered after the observations that
plasma ATX is constitutively active, LPC is abundant in plasma and serum, yet
LPA levels are low (Croset et al., 2000); (Eichholtz et al., 1993; Baker et al.,
2002; Sano et al., 2002). On the other hand, positive regulatory mechanisms
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likely also exist since serum LPA levels gradually increase following platelet
activation(van Meeteren and Moolenaar, 2007).
Physiological actions of LPA are mediated through the binding and
activation of specific plasma membrane receptors belonging to the superfamily of
G protein-coupled receptors (GPCRs) (Moolenaar, 1995, 1999; Chun et al.,
2002; Takuwa et al., 2002; Anliker and Chun, 2004; Fukushima, 2004; Valentine
et al., 2008). To date, there are six known LPA receptors. The three originally
identified receptors belong to the endothelial differentiation gene (Edg) family:
LPA1/Edg-2/vzg-1, LPA2/Edg-4 and LPA3/Edg-7 (Hecht et al., 1996; An et al.,
1998; Bandoh et al., 1999). More recently identified receptors are only distantly
related to the Edg family of receptors (20–24% sequence homology) and are
more closely related to the purinergic family of receptors: GPR23/P2Y9 (LPA4),
GPR92 (LPA5), P2Y5 (LPA6) GPR87(Noguchi et al., 2003; Kotarsky et al., 2006;
Lee et al., 2006a; Tabata et al., 2007; Yanagida et al., 2009). Further complexity
to the mechanism of LPA signaling is contributed by the discovery that PPARγ
can function as an intracellular LPA receptor (McIntyre et al., 2003).
Biochemical pathways other than the conversion of LPC via lysoPLD
activity have been identified to lead to the generation of LPA (Pages et al., 2001;
Aoki et al., 2002; Xie and Meier, 2004). Thus, biological actions of LPA are not
restricted to those described here involving ATX.
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ATX and disease
ATX's enzymatic lysoPLD activity has been implicated in a large variety of
biological processes during normal development and under pathological
conditions (Goding et al., 2003). Developmental roles include adipogenesis,
intestinal cell motility and neurite morphology (Sato et al., 2005; Simon et al.,
2005; Khurana et al., 2008), while a contribution to disease has been described
for Alzheimer's disease, chronic Hepatitis C, Multiple Sclerosis, neuropathic pain,
obesity and rheumatoid arthritis (Santos et al., 1996; Ferry et al., 2003;
Hammack et al., 2004; Boucher et al., 2005; Watanabe et al., 2007b; Watanabe
et al., 2007a; Inoue et al., 2008a; Inoue et al., 2008b; Zhao et al., 2008). The
functional importance of ATX's lysoPLD active site has, however, been
investigated most intensively during tumor progression and vascular
development.
Since its first description as a tumor cell motility stimulating factor for
human melanoma cells, ATX has been found expressed by a large variety of
tumor cells (Kawagoe et al., 1997; Yang et al., 1999; Zhang et al., 1999; Stassar
et al., 2001; Yang et al., 2002; Kehlen et al., 2004; Hoelzinger et al., 2005; Kishi
et al., 2006; Zhao et al., 2007). ATX promotes tumor cell penetration, metastatic
capability, tumor aggressiveness as well as tumor cell motility (Stracke et al.,
1992; Stracke et al., 1993; Kawagoe et al., 1997; Yang et al., 2002; Kishi et al.,
2006; Hoelzinger et al., 2008). In the search for the molecular mechanism
responsible for the tumor cell motility stimulating effect of ATX, a link with its
enzymatic activity and the involvement of G-protein-coupled receptors was found
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(Stracke et al., 1992; Lee et al., 1996a; Lee et al., 2002). However, it took the
identification of ATX as a lysoPLD to unravel that the above effects are mediated,
at least in part, via the conversion of LPC to LPA and via binding of LPA to one of
its high affinity receptors (Tokumura et al., 2002; Umezu-Goto et al., 2002; Koh
et al., 2003; Hama et al., 2004; Kishi et al., 2006; van Meeteren and Moolenaar,
2007; Hoelzinger et al., 2008).
The role of ATX in vascular development was revealed through the
generation of ATX null mice (Tanaka et al., 2006; van Meeteren et al., 2006).
ATX-deficient mice were found to die at midgestation (E9.5–E11.5) and to harbor
severe vascular defects that were in particular noticeable in the yolk sac.
Endothelial, smooth muscle and blood cell differentiation was not significantly
impaired however, newly formed blood vessels failed to develop into mature
vessels and this may be solely due to ATX's lysoPLD active site. Notably, in a
mouse line expressing only a lysoPLD inactivated ATX gene product, embryonic
lethality was observed to be similar to the one seen in the complete absence of
ATX (Ferry et al., 2007).

ATX: matricellular properties via the MORFO domain
Studies in our laboratory characterized ATX, which we referred to as PDIα/ATX, as an extracellular factor involved in the differentiation of
oligodendrocytes (Fox et al., 2003; Fox et al., 2004; Dennis et al., 2005; Dennis
et al., 2008). Most interestingly, these studies revealed a novel functionally active
domain, the MORFO domain, that 1) is located at the C-terminal end of the
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protein, 2) entails a nuclease-like domain not thought to be catalytically active
and 3) functions independently of ATX's enzymatic activity (see Fig. and
(Gijsbers et al., 2001; Fox et al., 2003; Fox et al., 2004; Dennis et al., 2005;
Stefan et al., 2005; Dennis et al., 2008). Early studies uncovered that the
MORFO domain antagonizes adhesion of oligodendrocytes to naturally occurring
extracellular matrix (ECM) molecules such as fibronectin in an active and
pertussis toxin-sensitive fashion (Fox et al., 2003). This finding classifies ATX as
a matricellular protein, i.e. a protein that mediates an intermediate adhesive
state, and it suggests a supportive role of ATX, via its MORFO domain, on
cellular remodeling (Murphy-Ullrich, 2001).
In agreement with the above, recent data have demonstrated that ATX's
MORFO domain facilitates morphological maturation of post-migratory,
premyelinating oligodendrocytes (Dennis et al., 2008). Post-migratory,
premyelinating oligodendrocytes mature from cells that extend a few processes
to cells that generate a highly complex process network, and it is this transition
that is facilitated by ATX's MORFO domain (Dennis et al., 2008). The role of ATX
in process outgrowth was found to be mediated in part via the EF hand-like motif
located at the far C-terminal end of the MORFO domain.

LPA-mediated oligodendrocyte effects
The role of ATX on oligodendrocytes has only been investigated by our
own laboratory but several other groups have studied LPA’s function in
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oligodendrocytes (Weiner et al., 1998; Moller et al., 1999; Stankoff et al., 2002;
Dawson et al., 2003; Yu et al., 2004).
Oligodendrocytes express LPA receptors and LPA has been shown to
exert a variety of effects on them (Allard et al., 1998; Weiner et al., 1998; Moller
et al., 1999; Handford et al., 2001; Stankoff et al., 2002; Dawson et al., 2003; Yu
et al., 2004; Nogaroli et al., 2009). LPA1 was the first LPA receptor found and its
expression correlates with neurogenesis during embryonic development and
myelination postnatally (Allard et al., 1998). Postnatally, LPA1 is expressed in
developing white matter tracks and co-expressed with the myelin proteins PLP
and MBP (Weiner et al., 1998; Cervera et al., 2002). Other investigators have
also reported expression of LPA1 in OPCs and oligodendrocytes (Handford et
al., 2001; Stankoff et al., 2002; Dawson et al., 2003; Yu et al., 2004; Matsushita
et al., 2005; Nogaroli et al., 2009), as well as LPA2 and LPA3 (Yu et al., 2004;
Matsushita et al., 2005; Nogaroli et al., 2009) and its expression in OPCs
increases as they differentiate (Dawson et al., 2003; Matsushita et al., 2005).
Oligodendrocytes also express LPA2 and LPA3 but at a much lower level than
LPA1 (Yu et al., 2004; Matsushita et al., 2005; Nogaroli et al., 2009). Along with
receptor expression, the highest tissue concentration of LPA has been found in
the brain (Das and Hajra, 1989) and so effects of LPA in the central nervous
system have been investigated.
In cultured oligodendrocytes, LPA modulates calcium signals and
activation of ERK1/2 (Moller et al., 1999; Stankoff et al., 2002; Yu et al., 2004).
LPA also exerts cytoskeletal effects such as process retraction and inhibition of
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process formation in OPCs but not in differentiated oligodendrocytes suggesting
different roles for LPA in oligodendrocyte development and differentiation
(Stankoff et al., 2002; Dawson et al., 2003). LPA stimulates astrocyte
proliferation (Shano et al., 2008), promotes survival in Schwann cells and in an
oligodendrocyte cell line but not in primary oligodendrocytes (Weiner and Chun,
1999; Stankoff et al., 2002; Li et al., 2003; Matsushita et al., 2005). Interestingly
jimpy mice, which have a mutation in the PLP gene and increased
oligodendrocyte apoptosis, exhibit lower expression levels of the LPA1 receptor
(Weiner et al., 1998). These findings indicate that LPA responses can vary not
only by cell type but also by developmental stage (at least in oligodendrocytes).
Due to the limited number of studies involving ATX and LPA function in
oligodendrocytes and the observation that ATX’s MORFO domain is important for
oligodendrocyte differentiation, the next question was whether ATX's lysoPLD
active site may also be involved in the regulation of oligodendrocyte
differentiation. LPA has already been shown to promote differentiation in
Schwann cells, cortical neuroblasts and in an oligodendrocyte cell line (Li et al.,
2003; Matsushita et al., 2005; Fukushima et al., 2007). The findings in chapter
two demonstrate that LPA, produced from ATX’s lysoPLD domain, are important
for differentiation of oligodendrocytes in vitro (Nogaroli et al., 2009).
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Figure 1.1. The oligodendrocyte lineage. This figure depicts both the changes
in morphology and gene expression that oligodendrocytes undergo as they
differentiate. OPCs are generated in restricted regions of the central nervous
system where they migrate from and proliferate extensively, populating the brain
and spinal cord. Once they have reached their destination, they begin to develop
a complex process network and eventually form membranous structures which
wrap around axons in vivo. As changes are observed morphologically,
oligodendrocytes also undergo changes in gene expression as shown
underneath the pictures. The markers listed are used to identify different stages
of the oligodendrocyte lineage: ganglioside (A2B5), platelet-derived growth factor
receptor (PDGFαR), pro-oligodendrocyte surface antigen or sulfatide (O4),
galactocerebroside (O1), 2,3-cyclic nucleotide 3-phosphodiesterase (CNP),
myelin basic protein (MBP), proteolipid protein (PLP), myelin oligodendrocyte
glycoprotein (MOG).
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Figure 1.2. Scheme of the structure–function domains of ATX. The Nterminal hydrophobic sequence of ATX is a signal peptide, thus resulting in the
secretion of the protein. Two somatomedin B-like domains are located at the Nterminal end of the protein. So far, no functional properties have been assigned
to these domains. The catalytic domain of ATX functions as lysoPLD thus
generating LPA, which exerts its effects through binding to G-protein-coupled
receptors (LPA1-5). Catalytic activity is dependent on the catalytic site residue
T210. At the C-terminal end, the Modulator of Oligodendrocyte Remodeling and
Focal adhesion Organization (MORFO) domain entails the nuclease-like domain,
which is probably enzymatically inactive. The functional properties of the MORFO
domain are thought to be mediated via binding to a yet-to-be-identified cell
surface receptor. The EF hand-like motif located at the far C-terminal end of the
protein was found to contribute to the function of the MORFO domain. The most
intensively characterized biological systems (Systems) and cellular molecular
mechanisms (Mechanisms) for each of the functionally active sites of ATX are
listed. Individual structure–function domains are depicted according to the gray
scale scheme shown at the bottom.
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CHAPTER 2
Lysophosphatidic acid can support the formation of membranous
structures and an increase in MBP mRNA levels in differentiating
oligodendrocytes
(This chapter was accepted as a paper in Neurochemical Research in June of
2008. The work reported for this manuscript was performed with assistance from
Dr. Luciana Nogaroli, Dr. Jameel Dennis and Karen Gorse. My own efforts on
this paper include the MBP studies, LPA receptor mRNA expression and ATX
enzymatic activity assay. The results are displayed in figures 2.1B and C, 2.2,
2.5A and B, 2.6A and B.)

Introduction
Oligodendrocytes are the myelin-forming cells of the central nervous
system (CNS). During development, they originate from progenitor cells that are
generated in discrete areas of the CNS and migrate to their final destination to
differentiate in a cell autonomous fashion into post-migratory, premyelinating
oligodendrocytes (Miller, 2002; Richardson et al., 2006). At the prospective sites
of myelination such post-migratory, premyelinating oligodendrocytes undergo
distinct stages of maturation, which are defined by changes in morphology and
gene expression pattern (see Fig.2.1A and (Kachar et al., 1986; Knapp et al.,
1987; Pfeiffer et al., 1993; Hardy and Friedrich, 1996; Dugas et al., 2006)). In
particular, cells first survey the environment for axonal segments to be
myelinated by extending a large and complex network of fine processes. This
step of extensive process outgrowth is followed by the transformation of cellular
protrusions into membranous structures ultimately forming the myelin sheath and
by the expression of proteins involved in the regulation of myelination such as
myelin basic protein (MBP) and myelin oligodendrocyte glycoprotein. Despite the

30

well described characterization of these maturation stages, however, little is
known about the signals that regulate their well coordinated progression
(Baumann and Pham-Dinh, 2001).
One of the extracellular factors long suspected to play a critical role during
the later stages of oligodendrocyte maturation is the lipid signaling molecule
lysophosphatidic acid (LPA). Extracellular LPA exerts its physiological functions
by activating specific G protein-coupled receptors (GPCRs; for review
see:(Birgbauer and Chun, 2006; Meyer zu Heringdorf and Jakobs, 2007; Choi et
al., 2008)). GPCRs of the endothelial differentiation gene family were the first to
be recognized as LPA receptors, and they are designated LPA1 (Edg-2), LPA2
(Edg-4) and LPA3 (Edg-7). In addition to these classical LPA receptors three
GPCRs of the purinergic family, GPR23/LPA4, GPR92/LPA5 and GPR87, have
been recently identified to also mediate signaling via LPA (Noguchi et al., 2003;
Lee et al., 2006; Tabata et al., 2007; Valentine et al., 2008). Out of the above,
LPA1 and LPA3 have been described to be expressed by differentiating
oligodendrocytes (Allard et al., 1998; Weiner et al., 1998; Allard et al., 1999;
Handford et al., 2001; Yu et al., 2004). The in vivo expression pattern of LPA1
was found to coincide with myelination, and it was this observation that prompted
a number of investigations into the role of LPA for oligodendrocyte differentiation
and function (Moller et al., 1999; Cervera et al., 2002; Stankoff et al., 2002;
Dawson et al., 2003). Somewhat disappointingly, no significant effects on
morphology and/or gene expression were identified in these studies.
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Differentiating oligodendrocytes express not only the receptors for
extracellular LPA, but also the major enzyme responsible for the production of
extracellular LPA, namely the lysophospholipaseD (lysoPLD) phosphodiesteraseIα/autotaxin (PD-Iα/ATX) (Narita et al., 1994; Fuss et al., 1997; Tanaka et al.,
2006; van Meeteren et al., 2006; Yuelling and Fuss, 2008). Our previous studies
identified PD-Iα/ATX as an extracellular factor that is released by differentiating
oligodendrocytes during the initial stages of myelination and that stimulates the
establishment of a complex process network independently of its lysoPLD activity
via a second functionally active domain, i.e. the modulator of oligodendrocyte
remodeling and focal adhesion organization (MORFO) domain (Fox et al., 2003;
Fox et al., 2004; Dennis et al., 2008). In addition, however, it is reasonable to
assume that the presence of PD-Iα/ATX in the extracellular environment of
differentiating oligodendrocytes results in the extracellular production of LPA and
in the stimulation of LPA-mediated effects. Thus, the limited responses observed
so far when adding LPA exogenously to differentiating oligodendrocytes may at
least be in part due to PD-Iα/ATX precluding or masking the physiological effects
of LPA.
In the present study we have, therefore, revisited the role of LPA on
differentiating oligodendrocytes, and we have assessed its effects under
conditions where the expression of PD-Iα/ATX was down-regulated. Under these
conditions, exogenous application of LPA was found to support the formation of
membranous structures and to stimulate an increase in mRNA levels coding for
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MBP but not MOG. Taken together, these findings demonstrate that LPA can
stimulate the later maturation steps of differentiating oligodendrocytes.

Experimental Procedures
Materials
Antibodies: Hybridoma clone A2B5 (ATCC, Manassas, VA), hybridoma
clone O4 (gift from S.E. Pfeiffer (Sommer and Schachner, 1982; Bansal et al.,
1989)), anti-LPA1 (Edg-2) antibodies (Abcam Inc., Cambridge, MA), anti-LPA2
(Edg-4) and anti-LPA3 (Edg-7) antibodies (Santa Cruz Biotechnology Inc., Santa
Cruz, CA), anti-acetylated α-tubulin antibodies (Zymed Laboratories Inc., South
San Francisco, CA), anti-MBP antibodies (Covance Berkeley, CA), secondary
Alexa 488- and Alexa 594-conjugated antibodies (Invitrogen/Molecular Probes,
Carlsbad, CA), secondary horseradish peroxidase (HRP)-conjugated antibodies
(Vector Laboratories, Burlingame, CA). The tyramide signal amplification (TSA)
Plus Cyanine 3 system was from Perkin Elmer (Waltham, MA). SMARTpool
siRNA directed against rat PD-Iα/ATX and control non-targeting SMARTpool
siRNA were obtained from Dharmacon Inc. (Lafayette, CO). Tissue culture and
transfection reagents were from Invitrogen (Carlsbad, CA) unless stated
otherwise. LPA (18:1-1-oleoyl-2-hydroxy-sn-glycero-3-phosphate) was
purchased from Avanti Polar Lipids Inc. (Alabaster, AL) as a 54.5 mM stock
solution prepared in chloroform. Oligonucleotide primers for PCR analysis were
from MWG-BIOTECH Inc (High Point, NC). RNA purification and RT kits were
obtained from Qiagen (Valencia, CA). The SYBR Green PCR mix was from
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BioRad (Hercules, CA). All other reagents and supplies were from Fisher
Scientific (Atlanta, GA) unless noted otherwise.

Animals
Sprague–Dawley female rats with early postnatal litters were obtained
from Zivic Miller (Pittsburg, PA) and Harlan (Indianapolis, IN). All animal studies
were approved by the Institutional Animal Care and Use Committee at Virginia
Commonwealth University.

Cell Culture, siRNA and LPA Treatment
Primary cultures of differentiating oligodendrocytes were prepared from brains of
postnatal day 4–5 rat pups as described previously (Barres et al., 1992; Fox et
al., 2003). Briefly, cerebral hemispheres were dissected out and single cell
suspensions were prepared by incubation in Hank’s Balanced Salt Solution
supplemented with 0.25% trypsin/1 μg/ml DNase (Sigma, St Louis, MO) and
subsequent trituration. Differentiating oligodendrocytes where then isolated by
O4 immunopanning. Isolated cells were placed on fibronectin (10 μg/ml)-coated
coverslips and cultured in serum-free defined medium [Dulbeccos’s Modified
Eagle’s Medium (DMEM) containing 40 ng/ml tri-iodo-thyronine (T3; Sigma, St
Louis, MO) and 1× N2 supplement (DMEM/T3/N2)]. After 2 days in culture, cells
were transfected with siRNA as described previously (Dennis et al., 2008). siPDIα/ATX- and siControl-treated cells were analyzed after an additional 48 h in
culture. Knock-down of PD-Iα/ATX was assessed by real-time qRT-PCR. When
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cells were treated with exogenous LPA, it was done for 2 h at a concentration of
1 μM (diluted in DMEM/N2). Immediately before use, the required aliquot of the
LPA stock solution was dried down under sterile conditions, and the lipid film was
resuspended by sonication in 0.4% fatty acid-free BSA (Sigma-Aldrich, St. Louis,
MO) dissolved in tissue culture medium.

PD-Iα/ATX-lysoPLD Activity Assay
PD-Iα/ATX’s lysoPLD activity was determined using the fluorogenic assay
described by Ferguson et al. (Ferguson et al., 2006). Cell culture supernatants
were incubated with 2.5 μM FS-3 substrate (Echelon Biosciences Inc., Salt Lake
City, UT) in 140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 5 mM Tris/HCl
(pH 8.0), 1 mg/ml fatty acid-free BSA (Sigma-Aldrich, St. Louis, MO) for 5.0 h at
37°C. Increase in fluorescence with time was measured at an excitation
wavelength of 485 nm and an emission wavelength of 520 nm using a
PHERAstar multimode microplate reader (BMG LABTECH Inc. Durham, NC).

Immunocytochemistry
For immunocytochemical detection of the O4 antigen as a marker for
differentiating oligodendrocytes in combination with one of the three classical
LPA receptors, cells were fixed in 4% paraformaldehyde dissolved in Phosphate
Buffered Saline (PBS). Unspecific binding sites were blocked using DMEM/10%
Fetal Calf Serum (FCS) and cells were incubated overnight at 4°C with O4
hybridoma supernatants (1:1 diluted in DMEM/10% FCS). Bound O4 antibodies
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were detected using Alexa 488-conjugated secondary antibodies (1:250 diluted
in PBS). Cells were then fixed again and incubated for 30 min in
blocking/permeabilization solution (PBS containing 5% normal goat serum, 2%
non fat dry milk and 0.05% Tween-20). Primary antibodies to each of the
classical LPA receptors were applied at a concentration of 1:100 (in PBS
containing 1% normal goat serum, 0.05% Tween-20) overnight at 4°C. Bound
primary antibodies were detected using the TSA Plus Cyanine 3 system. The
primary antibodies to the three classical LPA receptors used here have been
employed successfully by others (e.g. (Horak et al., 2007; Park et al., 2007)).
When tested for specificity by us using Western blot analysis of whole brain
lysates, all three antibodies were found to react with a single band of
approximately 40 kDa, which is consistent with the size of the receptor
monomers (data not shown). Furthermore, all antibodies detected an additional
band of approximately 80 kDa, likely representing previously described LPA
receptor homo- and/or heterodimers (Zaslavsky et al., 2006).
For immunocytochemical detection of MBP, cells were fixed in 4%
paraformaldehyde dissolved in PBS and permeabilized using 0.5% triton/0.4 M
sucrose in PBS. Subsequently, cells were incubated for 30 min in DMEM/10%
FCS and then overnight with anti-MBP antibodies (1:250 diluted in DMEM/10%
FCS). Bound primary antibodies were detected using Alexa 488-conjugated
secondary antibodies (1:250 diluted in PBS) and nuclei were stained using
Hoechst (1 μg/ml; Calbiochem, San Diego, CA).
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For immunocytochemical detection of the O4 antigen in combination with
acetylated α-tubulin the treatment for O4 immunostaining was as described
above. Bound O4 antibodies were detected using Alexa 594-conjugated
secondary antibodies (1:250 diluted in PBS). Cells were then fixed again and
permeabilized using 0.5% TRITO-X100 in PBS. Following permeabilization cells
were incubated in DMEM/10% FCS and then overnight with anti-acetylated αtubulin antibodies. Bound antibodies were detected using Alexa 488-conjugated
secondary antibodies (1:250 diluted in PBS).
Cells were analyzed using an Olympus BX51 inverted fluorescent
microscope (Olympus America Inc., Center Valley, PA) or a confocal laser
scanning microscope (TCS SP2 AOBS, Leica Microsystems, Exton, PA or LSM
510 META, Carl Zeiss MicroImaging, Inc., Thornwood, NY).

Real-Time qRT-PCR Analysis
Total RNA was isolated from oligodendrocyte cultures using the RNeasy
Micro Kit. Purified RNA samples were quantified by fiber optic spectrophotometry
using the Nanodrop ND-1000 (Nanodrop Inc., Wilmington, DE) and their quality
was assessed using Experion RNA HighSens Chips (BioRad, Hercules, CA). For
real-time qRT-PCR, oligo(dT)-primed cDNAs were synthesized using the
Sensiscript or Omniscript RT kit. PCR was performed on a Chromo 4 Four-Color
Real-Time System (BioRad, Hercules, CA) using the iQ SYBR Green Supermix.
The following primer pairs were used at the indicated annealing temperatures:
PD-Iα/ATX: forward (5′-GACCCTAAAACCATTATTGCTAA-3′), reverse (5′-
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GGGAAGGTGCTGTTTCATGT-3′), 60°C; MBP (exon 2 containing isoforms)
forward (5′-ACTTGGCCACAGCAAGTACCATGGACC-3′), reverse (5′TTGTACATGTGGCACAGCCCGGGAC-3′), 60°C; MOG: forward (5′CTCATTGCCCTTGTGCCTAT-3′), reverse (5′-GCACGGAGTTTTCCTCTCAG3′), 60°C; LPA1 (Edg-2): forward (5′-GACACCATGATGAGCCTTCTGA-3′),
reverse (5′-CCCGGAGTCCAGCAGACA-3′), 65°C; LPA2 (Edg-4): forward (5′CGCTCAGCCTAGTCAAGACA-3′), reverse (5′TTGCAGGATTTACAGTCCAGAC-3′), 65°C; LPA3 (Edg-7): forward (5′CACACGAGTGGCTCCATCAG-3′), reverse (5′-GGTCCAGCACACCACGAA-3′),
65°C. For normalization, amplification of 18S rRNA was performed: forward (5′TTCGGAACTGAGGCCATGAT-3′), reverse (5′-TTTCGCTCTGGTCCGTCTTG3′), 60 or 65°C. PCR conditions were as follows: 95°C for 15 min followed by 34
cycles at 94°C for 15 s, annealing temperature for 20 s, and 72°C for 20 s. For
quantification of relative LPA receptor mRNA levels, the method described by
Peirson et al. (Peirson et al., 2003) was used. For relative comparison of MBP
and MOG mRNA levels in the presence of siPD-Iα/ATX or siControl, the ΔΔCT
method was used (Livak and Schmittgen, 2001).

Oligodendrocyte Morphology Analysis
For morphology analysis, cells were immunostained using the O4 antibody
and an anti-acetylated α-tubulin antibody. Images of approximately 40 cells were
taken randomly for each treatment group in each experiment using an Olympus
BX51 inverted fluorescent microscope (Olympus America Inc., Center Valley,
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PA). IP Lab imaging software (BD Biosciences Bioimaging, Rockville, MD) was
used to determine process index (total amount of O4-positive process surfaces
per cell minus the cell body), network area (total area within the radius of the
process network surrounding the cell body minus the cell body) and complexity
index (1 minus process index divided by network area) as previously described
(Dennis et al., 2008). In addition, a membrane index was defined as follows: [(O4
network area minus acetyl-tubulin network area) divided by the O4 network area].
A 1:1 correlation of network area to microtubule area yields values approaching
0, while a membranous network area considerably larger than the microtubule
network area produces a membrane index approaching 1.

Cell Count Analysis (MBP-Positive Cells)
Composite images of MBP-positive cells were collected by tile scan using
a Leica TCS SP2 AOBS confocal microscope (Leica Microsystems, Exton, PA).
The total number of detectable nuclei and MBP-positive oligodendrocytes was
determined using the particle count plugin (Wright Cell Imaging Facility) to the
ImageJ software package (Abramoff et al., 2004) and the following parameters:
nuclei (threshold size: 0–10, circularity: 0–1.0); MBP (threshold size: 0.5–5.0,
circularity: 0–1.0).

Results
Differentiating Oligodendrocytes Express Enzymatically Active PD-Iα/ATX
and all Three Classical LPA Receptors
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Prior to analyzing the role of LPA on differentiating oligodendrocytes,
studies were undertaken to confirm the enzymatic activity of secreted PD-Iα/ATX
and the expression of LPA receptors in the culture system to be used.
Differentiating oligodendrocytes were isolated from brains of 4 to 5 day-old rats
by O4 immunopanning and allowed to mature for 4 days in vitro. The antigenic
marker O4 has been previously demonstrated to be present on the membrane
surface of oligodendrocytes that are considered post-migratory, premyelinating
cells (Sommer and Schachner, 1981, 1982; Bansal et al., 1989; Warrington et al.,
1992). In addition, such O4-positive oligodendrocytes release endogenous PDIα/ATX and start to express MBP and MOG (Fig. 2.1A and (Pfeiffer et al., 1993;
Solly et al., 1996; Fox et al., 2003)). To determine lysoPLD activity of the
secreted PD-Iα/ATX, cell culture supernatants were tested using a fluorogenic
assay in which enzymatic activity is measured in a concentration and time
dependent manner via an increase in fluorescence (Fig. 2.2 and (Ferguson et al.,
2006)). Using this assay, cell culture supernatants of differentiating
oligodendrocytes were found to contain significant amounts of enzymatically
active PD-Iα/ATX (see Fig. 2.1B). This finding is in agreement with our previous
data demonstrating an increase in PD-Iα/ATX expression levels during the initial
stages of myelination (Fox et al., 2003). In contrast, oligodendrocyte progenitor
cells were found to be negative for PD-Iα/ATX mRNA, and only low levels of PDIα/ATX mRNA were detected in oligodendrocytes present in the adult CNS
(unpublished observations and (Fuss et al., 1997)).
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To assess LPA receptor expression, RNA was isolated from differentiating
oligodendrocyte cultures and analyzed using real-time qRT-PCR. Amplification
products for all three classical LPA receptors were noted. Quantification of the
mRNA expression levels revealed highest expression of LPA1 followed by LPA3
and LPA2 (Fig. 2.1C). The data related to LPA1 and LPA3 expression are
consistent with previous findings (Stankoff et al., 2002; Yu et al., 2004).
Expression of LPA2, however, may have been overlooked so far due to its very
low expression levels. To further confirm the expression of the three classical
LPA receptors by differentiating oligodendrocytes, we took advantage of the
availability of specific antibodies. As shown in Fig. 2.1D all three receptors were
detected in O4-positive cells of both simple and complex process morphology. In
addition, a punctate distribution was noted that may be indicative of receptor
localization to intracellular vesicles. Taken together, the above data confirm and
extend the finding that differentiating oligodendrocytes secrete enzymatically
active PD-Iα/ATX and express receptors known to mediate signaling by
extracellular LPA.

Extracellular LPA can Support an Increase in Oligodendrocyte Network
Area via Stimulation of the Formation of Membranous Structures
As introduced above, the presence of PD-Iα/ATX in the extracellular
environment of differentiating oligodendrocytes may preclude and/or mask some
of the physiologic effects of LPA when it is added exogenously and/or in excess.
Thus, we analyzed the effect of exogenous LPA on the morphology of
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differentiating oligodendrocytes under conditions where PD-Iα/ATX expression
was down-regulated. Differentiating oligodendrocytes were isolated by O4
immunopanning from postnatal day 4 to 5 rat brains and treated with a siRNA
pool specific to PD-Iα/ATX 2 days after plating. We have previously established
that under these conditions PD-Iα/ATX mRNA and protein levels are reduced by
at least 50% 48 h after siRNA treatment (Dennis et al., 2008). For LPA treatment
a concentration of 1 μM was chosen. At this concentration significant effects on
Ca2+ mobilization and ERK1/2 activation have been described by others (Moller
et al., 1999; Stankoff et al., 2002; Yu et al., 2004). Furthermore, for the LPAinduced increase in pERK an EC50 of 1 μM has previously been established (Yu
et al., 2004). LPA was added 48 h after siRNA treatment and its effects were
evaluated 2 h after application. We first determined the network area as a
measure for morphological changes (Fig. 2.3A). In agreement with previous
studies, no effects were noted under control conditions (Fig. 2.3B and (Stankoff
et al., 2002)). At reduced levels of PD-Iα/ATX mRNA and protein, however, the
network area was significantly reduced, and addition of LPA led to an increase to
almost control levels (Fig. 2.3B).
To further define the nature of the morphological changes observed in
response to LPA, process and complexity indices were determined (see
Experimental Procedures and (Dennis et al., 2008)). As shown in Fig. 2.4A,
treatment of differentiating oligodendrocytes with a siRNA pool specific to PDIα/ATX resulted in a decrease in both process and complexity indices. Thus,
siPD-Iα/ATX-treated cells displayed a simple process morphology (Fig. 2.4B;
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upper panel). Upon addition of exogenous LPA to these cells, an increase in
process but not complexity index was noted (Fig. 2.4A). Such an increase could
either be due to an increase in long, unbranched processes or in membranous
structures. When visually inspecting the cells, the latter appeared to be the case
(an example of maximal effect is depicted in Fig. 2.4B; lower panel). To quantify
this effect, cells were double stained for O4 and acetylated α-tubulin, a protein
associated with stabilized microtubules (Piperno et al., 1987). In
oligodendrocytes, stabilized microtubules are found in processes of
differentiating cells but not within their membranous structures (Lunn et al., 1997;
Richter-Landsberg, 2001; Liu et al., 2003; Lee et al., 2005; Li et al., 2007b).
Thus, the differential in distribution of the O4 antigen versus acetylated α-tubulin
allowed us to define a membrane index for which a value close to 1 is
characteristic for cells extending large membranous areas while a lower value
denotes the presence of fine processes (for details see Experimental
Procedures). As shown in Fig. 2.4C, the membrane index remained unaffected
when PD-Iα/ATX expression was down-regulated. This finding is in agreement
with our previous studies, and it reflects a decrease in the number of cells
extending a complex network of fine processes (Dennis et al., 2008). Application
of LPA to these cells of relatively simple process morphology significantly
increased the membrane index (Fig. 2.4C). Thus, LPA can induce an increase in
the oligodendrocyte’s network area by stimulating the formation of membranous
structures.
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Extracellular LPA can Support an Increase in the Number of MBP-Positive
Cells via Stimulation of an Increase in MBP mRNA Levels
In an attempt to gain insight into potential molecular mechanisms
underlying the above observed effect of LPA on the formation of membranous
structures, the expression of the classic isoforms of the myelin protein MBP was
analyzed (Figs. 2.5 and 2.6). These MBP isoforms are highly expressed during
the active stages of myelination and are thought to have regulatory effects on the
myelination program (Barbarese et al., 1978; Campagnoni et al., 1978; Staugaitis
et al., 1996; Kimura et al., 1998; Campagnoni and Campagnoni, 2004; Boggs,
2006). As shown in Fig. 2.5, down-regulation of PD-Iα/ATX expression led to a
decrease in the number of MBP-positive cells. Upon addition of LPA, the number
of MBP-positive cells returned to at least control levels.
The observed increase in the number of MBP-positive cells could be
mediated by stimulation of gene expression or by regulatory posttranscriptional
events such as mRNA transport and/or translational regulation. To evaluate the
contribution of an increase in mRNA levels, real-time qRT-PCR was performed.
In these studies, mRNAs coding for the exon 2-containing classic isoforms of
MBP were assayed since these are expressed more abundantly during the initial
stages of myelination. In contrast, exon 2-deficient MBP isoforms have been
implicated primarily in the regulation of myelin maintenance and/or compaction
[59, 60]. Cells treated with a siRNA pool specific to PD-Iα/ATX displayed a
reduction in MBP mRNA levels that was similar to the reduction in the number of
MBP-positive cells (compare Fig. 2.6A with Fig. 2.5B). In contrast to MBP, MOG,
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which is specifically expressed by myelinating oligodendrocytes, was not affected
by the alteration in PD-Iα/ATX expression (Fig. 2.6A and (Solly et al., 1996)).
These findings demonstrate that a reduction in PD-Iα/ATX expression affects
mRNA levels for some but not all myelin genes. Upon treatment with LPA, MBP
mRNA levels were increased by a factor of 2.9, while MOG mRNA levels
remained unchanged (Fig. 2.6B). Interestingly, MBP mRNA levels reached above
control levels after LPA application. This enhancement in MBP mRNA levels
could either reflect a more efficient direct effect of LPA on MBP under low PDIα/ATX expression conditions, or it could, in part, be a consequence of an indirect
or off-target effect of the siPD-Iα/ATX-treatment on other LPA-responsive genes.
Nevertheless, these data demonstrate that under certain conditions LPA can
induce an increase in the mRNA levels encoding classic isoforms of MBP.

Discussion
The well coordinated sequence of events leading to the final maturation of
differentiating oligodendrocytes is crucial for proper functioning of the CNS. Our
data presented here indicate that the lipid signaling molecule LPA may play a
crucial role in regulating these events. In particular, we found that LPA can
promote an increase in the area occupied by the oligodendrocyte’s process
network by stimulating the extension of membranous structures. In addition, LPA
can increase the appearance of MBP-positive cells via stimulation of an increase
in MBP mRNA levels. mRNA levels for the later stage marker MOG, however,
appeared unaffected. Increases in neither the network area nor the MBP mRNA
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levels were observed under control conditions. Detection of these exogenous
LPA-mediated effects required prior down-regulation of PD-Iα/ATX expression.
Thus, our data demonstrate that under conditions where PD-Iα/ATX expression
is down-regulated LPA can promote the transition from a network of fine
processes to the formation of myelin sheets as well as an increase in MBP
mRNA levels (Fig. 2.7).
In the studies presented in Fig. 2.4, the formation of membranous
structures was induced by LPA in cells of simple process morphology. In vivo
and under control in vitro conditions, however, membrane sheath formation is
preceded by the extension of a complex process network (Knapp et al., 1987;
Hardy and Friedrich, 1996). Thus, for earlier differentiation stages of
oligodendrocytes with simple morphology LPA does not appear to exert a similar
effect as the one observed here. These cells may lack components of the
signaling pathway leading to membrane sheath formation and/or this pathway
may be inhibited by the expression of “silencing” factors. In either case, downregulation of PD-Iα/ATX does not seem to affect the crucial components of these
pathways. In an extended interpretation, these findings suggest that downregulation of PD-Iα/ATX does not block the entire differentiation program in
maturing cells of the oligodendrocyte lineage.
LPA-mediated effects on oligodendrocyte network area and MBP mRNA
levels were only revealed after down-regulation of PD-Iα/ATX expression.
Interestingly, in the case of the membrane index, a slight increase was observed
upon LPA application under control conditions, i.e. without prior down-regulation
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of PD-Iα/ATX expression (data not shown). This effect was, however, not
associated with a concomitant increase in network area (see Fig. 2.3). Thus, the
increase in membrane index under control conditions appears primarily due to a
decrease in acetylated α-tubulin that is likely associated with a rearrangement
from fine and complex process networks to membranous structures. Myelin
sheath formation has been recently suggested to involve destabilization of
microtubules and deacetylation of α-tubulin (Southwood et al., 2007). Thus, the
LPA-mediated effect on oligodendrocyte morphology may be associated with
cytoskeletal rearrangements involved in the transition from process outgrowth to
membrane sheath formation. In support of this idea, it has been previously
shown that LPA induces rearrangements of microtubules during remodeling of
neuronal processes (Sayas et al., 2002; Fukushima and Morita, 2006).
Down-regulation of PD-Iα/ATX was found here to negatively affect MBP
expression. Subsequent application of LPA reverted this effect. These data point
toward a role of LPA on the expression of certain genes known to be important
for myelination. Up-regulation of gene expression within hours of LPA application
has been previously reported to occur and to be mediated by signaling through
LPA receptors (Lee et al., 2004; Cui et al., 2006; Lee et al., 2006b; Klemm et al.,
2007). Accordingly, the LPA-mediated effects described here are thought to be
mediated by signaling through one or more of the cell surface LPA receptors
expressed by differentiating oligodendrocytes. Upon agonist stimulation, most
GPCRs are rapidly internalized into cells through endocytic pathways. Indeed,
LPA receptor activation has been associated with vesicle-mediated endocytosis
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(Luttrell et al., 1997; Kranenburg et al., 1999; Murph et al., 2003; Urs et al.,
2005). Our immunostaining for LPA1 through three revealed a punctate pattern
indicative of LPA receptor localization to intracellular vesicles. Thus, LPA
receptor activation is likely operative in cultures of primary oligodendroglial cells
as utilized here. We consider it unlikely that the effects we observe are mediated
via the recently discovered nuclear LPA receptor (PPARγ) since extracellular
LPA has long been known to have access to the intracellular compartment only
when applied in a carrier (albumin)-free manner (Tokumura et al., 1992; McIntyre
et al., 2003). Knock-out mice for LPA receptors have so far not revealed any
specific myelination defects (Contos et al., 2002; Yang et al., 2002; Ye et al.,
2005). This observation, however, does not minimize the predicted importance of
LPA receptor signaling for oligodendrocyte differentiation and myelination. The
existence of an increasing number of LPA receptors and the redundancy of
lysophospholipid-evoked cellular responses create a scenario of great complexity
(Valentine et al., 2008). Thus, more sophisticated strategies may have to be
employed to be able to dissect in vivo the physiological roles for each of the LPA
receptors.
In summary, the data presented here reveal a potentially crucial role for
LPA during the later stages of oligodendrocyte maturation. Due to the
heterogeneity of the oligodendrocyte cultures with respect to their developmental
stage, we cannot rule out the possibility that the LPA-mediated effects observed
here are limited to a narrow developmental window. Nevertheless, these effects
were only revealed after down-regulation of PD-Iα/ATX expression. In light of the

48

well established role of PD-Iα/ATX as the major enzyme generating exogenous
LPA, it is, therefore, tempting to speculate that during normal development LPA
is generated in the environment surrounding the maturing oligodendrocyte via
PD-Iα/ATX’s lysoPLD active site. This generation of exogenous LPA can, at the
appropriate developmental time point, promote the transition from a highly
branched network of fine processes to myelin sheath formation associated with
an increase in MBP expression. Interestingly, the prior establishment of the
complex network of fine processes is facilitated by PD-Iα/ATX’s second
functionally active site, the MORFO domain (Dennis et al., 2008). Thus, PDIα/ATX seems to promote oligodendrocyte maturation via the concerted action of
its functionally active sites. Future studies will, however, be necessary to dissect
the exact roles of PD-Iα/ATX for myelination during normal development and
during myelin repair under pathological demyelinating conditions.
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Figure 2.1. Differentiating oligodendrocytes secrete enzymatically active
PD-Iα/ATX and express all three classical LPA receptors. (A) Scheme of
morphological and gene expression characteristics of differentiating
oligodendrocytes. At all stages oligodendrocytes express the cell surface antigen
O4 and the secreted protein phosphodiesterase-Iα/autotaxin (PD-Iα/ATX). The
myelin proteins myelin basic protein (MBP) and myelin oligodendrocyte
glycoprotein (Sato et al.) are expressed with increasing stages of maturation. (B)
PD-Iα/ATX’s lysoPLD activity was determined in tissue culture supernatants from
O4 immunopanned oligodendrocytes (4 days after plating) using the fluorogenic
assay described by Ferguson et al. [37]. Means ± SEM of three independent
experiments done in triplicates are shown. Numbers on the Y-axis represent
fluorescence increase as a measure for lysoPLD activity in arbitrary units. (C)
Relative LPA receptor mRNA levels present in differentiating oligodendrocytes.
mRNA levels were determined by real-time qRT-PCR [41] and are presented in
% on a logarithmic scale. LPA1 mRNA levels were set to 100% and the levels for
LPA3 and LPA2 calculated accordingly. Means ± SEM of three pooled samples
run in triplicate are shown. (D) Immunocytochemistry of differentiating
oligodendrocytes. Oligodendrocytes were isolated by O4 immunopanning and
double-immunostained 4 days after plating for the O4 antigen and for LPA1, 2 or
3. Scale bar: 20 μm
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Figure 2.2. Time- and concentration-dependent measurement of PDIα/ATX’s lysoPLD activity. PD-Iα/ATX’s lysoPLD activity was determined in
tissue culture supernatants from O4 immunopanned oligodendrocytes (4 days
after plating) using the fluorogenic assay described by Ferguson et al. (2006).
Means ± SEM of a typical experiment done in triplicates is shown. Numbers on
the Y-axis represent fluorescence increase as a measure for lysoPLD activity in
arbitrary units. μg values represent amounts of input protein.
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Figure 2.3. LPA can induce an increase in network area under conditions
where PD-Iα/ATX expression is down-regulated. Differentiating O4-positive
oligodendrocytes isolated from brains of 4 to 5 day-old rats were treated with a
control (Control) or PD-Iα/ATX-specific (siPD-Iα/ATX) siRNA SMARTpool. 48 h
after siRNA transfection, LPA was applied at a concentration of 1 μM for 2 h.
Cells were then immunostained with the O4 antibody and the area covered by
each cell’s process network was determined. (A) Representative example of an
oligodendrocyte labeled for the O4 antigen (left panel; confocal image
representing a 2D maximum projection of stacks of 0.5 μm optical sections) and
its network area (right panel). Scale bar: 20 μm. (B) Bar graph depicting the
network area in % of control (mean of control = 100%). Means ± SEM of four
independent experiments are shown. Stars indicate overall two-tailed
significance levels of P < 0.05 as determined by Student’s t-test
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Figure 2.4. LPA-induced increase in network area is due to an increase in
the establishment of membranous structures. Differentiating
oligodendrocytes were isolated and treated as described in Fig. 2.
(A) Normalized values of the cells’ process indices were plotted against
normalized values of their complexity indices on logarithmic scales (mean control
values = 50; see dashed lines). The numbers in each of the quadrants represent
% cells. Four independent experiments with at least 30 cells per condition are
shown. (B) Upper panel: representative example of a siPD-Iα/ATX-treated cell
that is characterized by a low membrane index. Lower panel: representative
example of a siPD-Iα/ATX plus LPA-treated cell that is characterized by a high
membrane index. Images were obtained by confocal microscopy and represent
2D maximum projections of stacks of 0.5 μm optical sections. Scale bar: 20 μm.
(C) Bar graph depicting membrane indices. Means ± SEM of two independent
experiments are shown. Stars indicate overall two-tailed significance levels of
P < 0.05 as determined by Student’s t-test

56

57

Figure 2.5. LPA can induce an increase in the number of MBP-positive cells
under conditions where PD-Iα/ATX expression is down-regulated.
Differentiating oligodendrocytes were isolated and treated as described in Fig. 2.
(A) Representative images of cultures of differentiating oligodendrocytes treated
with siPD-Iα/ATX (upper panel) or siPD-Iα/ATX plus LPA (lower panel). Cells
expressing the classic isoforms of MBP were visualized by immunocytochemistry
and nuclei were detected by Hoechst staining. Images were obtained by confocal
microscopy and represent 2D maximum projections of stacks of 0.5 μm optical
sections. Scale bar: 75 μm. (B) Bar graph depicting the number of MBP-positive
cells as % of control. Control values were set to 100%. Means ± SEM of three
independent experiments are shown. Stars indicate overall two-tailed
significance levels of P < 0.05 as determined by Student’s t-test
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Figure 2.6. LPA-induced increase in the number of MBP-positive cells is due
to an increase in MBP mRNA levels. Differentiating oligodendrocytes were
isolated and treated as described in Fig. 2. mRNA levels for MBP and MOG were
determined by real-time qRT-PCR [42]. 18S rRNA was used for normalization.
(A) Bar graph depicting mRNA levels as % of control (control levels were set to
100%). (B) Bar graph illustrating the fold increase in mRNA levels upon LPA
treatment (mRNA levels under siPD-Iα/ATX conditions were set to 1; see dotted
line). For both graphs, means ± SEM of three independent experiments done in
duplicates are shown. Stars indicate an overall two-tailed significance level of
P < 0.05 as determined by Student’s t-test.
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Figure 2.7 Potential effects of LPA on differentiating oligodendrocytes.
Our data presented here demonstrate that extracellular LPA can stimulate the
formation of membranous structures and an increase in mRNA levels encoding
classic isoforms of MBP at least under conditions where PD-Iα/ATX expression is
down-regulated.

62

63

CHAPTER 3
Introduction to zebrafish oligodendrocyte development and myelination
During the last 20 years, the zebrafish has emerged as a model system
for the study of vertebrate development. In the early 1970’s, George Streisinger
at the University of Oregon discovered this potential in the zebrafish and is
considered the founding father of zebrafish research. The work done by his
group stimulated interest in other laboratories and led to the validation of the
zebrafish as an important developmental and genetic model.

Zebrafish
The zebrafish, Danio rerio, is a freshwater fish found naturally around the
Ganges and Brahmaptura river basins in northeastern India, Bangladesh and
Nepal. The name Danio is derived from the Bengali name “dhani” meaning “of
the rice field” (Talwar and Jhingran, 1991).
Fishes are a very large and diverse group of vertebrates. They include the
jawless fishes (hagfish and lampreys), cartilaginous fishes (sharks, rays and
skates) and bony fishes (ray-finned and lobe-finned fishes). The ray-finned fishes
(Class Actinopterygii) have more than 23,500 different species and make up
more than 95% of all fish species and about half of all non-extinct vertebrate
species. Zebrafish belong to the teleost infraclass of the actinopterygians which
make up about 99.8% of all ray-finned fishes. Other examples of teleosts used in
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research include the rainbow trout, Atlantic salmon and the well-studied
Japanese medaka (Volff, 2005).
Teleost fish are the most diverse and species-rich vertebrate group likely
because of duplication events that have occurred in their genome (Ohno, 1970;
Postlethwait et al., 2004; Volff, 2005). Duplicate pairs of genes generated by this
event have been maintained over hundreds of millions of years of evolution
(Volff, 2005). Also many genes present in higher vertebrates are present in the
zebrafish genome (Barbazuk et al., 2000). These homologous genes can be
referred to as either paralogs (separated by a speciation event) or orthologs
(separated by a genome duplication event).
Tetrapods, land dwelling vertebrates with four limbs (amphibians, reptiles,
birds and mammals), have been considered to be descendants of lobe-finned
fishes. Bony fishes are more related to lobe-finned fishes than evolutionarily
older jawless and cartilaginous fishes and are therefore are more related to
tetrapods, suggesting that teleosts share a common fish ancestor with tetrapods
allowing the use of fish for the study tetrapodal processes (Volff, 2005). Because
of this potential and the advantages described below, the zebrafish has become
an important vertebrate model in developmental biology. Many favorable
characteristics of zebrafish for study in the laboratory include their small size and
robustness and relatively cheap maintenance. They can breed throughout the
year, two to three times a week, with clutch sizes around a couple of hundred
eggs. Fertilization is external and embryos are optically clear allowing for easy
manipulation and visualization under a microscope. Their embryos are smaller
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and have less numbers of cells than tetrapod embryos, making it easy to trace
the development of individual cells. Embryogenesis is rapid and complete by 3
days post fertilization (dpf) with a full body axis and major neurons being laid
down by 24 hours post fertilization (hpf) and precursors to major organs
developed by 36 hpf (Kimmel et. al., 1995). Developmental staging of zebrafish
has also been very well characterized (Kimmel et al., 1995) and orthologs for
most human genes can be found and studied in zebrafish (Barbazuk et al., 2000;
Postlethwait et al., 2000).
Many methods are available for the study of developmental processes in
the zebrafish. Visualizing cells within a whole embryo can be carried out using
whole mount in situ hybridization or whole mount immunohistochemistry. Also,
transgenic zebrafish with tissue-specific promoters that drive fluorescent protein
expression allow the visualization of cells in living zebrafish. Knock down
technologies such as the use of antisense morpholino oligonucleotides allow
easy manipulation of gene function in developing embryos.
These methods as well as similarities in central nervous system
development, including oligodendrocyte development, between zebrafish and
mammals described below allow us to undertake studies of ATX in this model.

CNS development in the zebrafish - overview
The neural tube of zebrafish embryos is like that of other vertebrates in
that it is highly polarized along its dorsoventral axis. In the spinal cord, sensory
neurons form at the dorsal locations while motor neurons and oligodendrocytes
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develop at ventrolateral regions. The floor plate develops at ventral regions and
interneurons occupy the intermediate regions (Blader and Strahle, 2000).
The first neurons become post mitotic shortly after gastrulation and by the
end of the first day post fertilization embryos generate movements by
spontaneous twitching. During the second day post fertilization, embryos can
respond to touch because of the presence of differentiated neurons and
pioneering axons. This is important for a startle response required for escape in
the wild (Blader and Strahle, 2000).

Oligodendrocyte specification/early development
Oligodendrocyte development and differentiation occur later in
development than neurons as in the mammalian system. Oligodendrocytes also
share cell lineage similarities with mammalian oligodendrocytes, including
specification, development and myelination as well as many of the genes
involved in these processes (Buckley et al., 2008). Unless otherwise noted, the
mechanisms described in this chapter are conserved between zebrafish and
mammals.
Oligodendrocytes are reported to first arise between 24hpf to 36hpf in the
midbrain and hindbrain and from 36hpf to 48hpf in the spinal cord of the
developing zebrafish (Park et al., 2002; Kirby et al., 2006; Li et al., 2007a;
Schebesta and Serluca, 2009).
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The majority of information known for oligodendrocyte specification has
been gained from study in the developing spinal cord therefore the descriptions
below are limited to spinal cord-derived oligodendrocytes.
In order for oligodendrocytes to be specified in the spinal cord, the
notochord must first develop. The notochord is a transient, embryonic midline
structure in vertebrates important for fate determination of surrounding tissues
(Stemple, 2005). In the central nervous system, it is required for the formation of
the dorsal-ventral axis of the overlying neural tube, including specification of the
floor plate, the ventral-most portion of the spinal cord (van Straaten et al., 1989;
Placzek et al., 1990; van Straaten and Hekking, 1991; Dodd et al., 1998). This
dorsoventral patterning of the developing neural tube is dependent on the
notochord-derived glycoprotein sonic hedgehog (SHH) in a high to low
concentration dependent manner (Fig. 3.1) (Tanabe and Jessell, 1996; Ericson
et al., 1997; Wilson and Maden, 2005; (Ericson et al., 1995).
OPCs are generated adjacent to the floor plate in the same location that
gives rise to motor neurons, the motor neuron progenitor domain (Fig. 3.1) (Warf
et al., 1991; Noll and Miller, 1993; Pringle and Richardson, 1993; Yu et al., 1994)
and their specification begins when motor neuron production has ended
(Richardson et al., 2000; Zhou and Anderson, 2002; Park et al., 2004).
After the floor plate is induced, it also releases SHH, important for OPC
specification (Poncet et al., 1996; Pringle et al., 1996; Orentas et al., 1999; Park
et al., 2002; Park et al., 2004). SHH is also important for specification of motor
neurons and interneurons in a high to low (ventral to dorsal) concentration
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gradient, where motor neurons and oligodendrocytes require the same
concentration (Pringle et al., 1996; Ericson et al., 1997; Orentas et al., 1999).
Transcriptional regulation is very important for the timely and proper
development and differentiation of oligodendrocytes. Shh regulates the
expression of many transcription factors, including genes known to be expressed
early during oligodendrocyte lineage progression (olig1 and olig2), which encode
basic helix-loop-helix transcription factors. They were first identified in areas of
the neuroepithelium where oligodendrocytes arise (Lu et al., 2000; Zhou et al.,
2000; Park et al., 2002b). More specifically, olig1 and olig2 are expressed in cells
of the motor neuron domain, where oligodendrocytes and motor neurons are
generated (Zhou et al., 2000).
Olig2 is necessary for the specification of both motor neurons and
oligodendrocytes as mice and zebrafish lacking olig2 display an absence of both
cell types (Lu et al., 2002; Takebayashi et al., 2002; Zhou and Anderson, 2002;
(Park et al., 2002).
olig1 null mice reveal that olig1 is necessary for oligodendrocyte
maturation and not specification (Lu et al., 2002; Xin et al., 2005). olig1 is
important during oligodendrocyte development in the brain only in the absence of
olig2 suggesting that, at least in restricted areas, olig1 expression is sufficient for
oligodendrocyte development (Lu et al., 2002). This observation was also
confirmed by a complete lack of oligodendrocyte generation in olig1/olig2 doublenull mice (Zhou and Anderson, 2002). Consistent with olig1’s role in
oligodendrocyte maturation, other studies have shown its importance in
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oligodendrocyte differentiation by regulating transcription of the major myelinspecific genes, mbp, plp and mag, as well as in myelinogenesis (Xin et al., 2005)
and during remyelination in a demyelination model (Arnett et al., 2004). In the
zebrafish, olig1 is expressed by oligodendrocytes (Li et al., 2007a; Schebesta
and Serluca, 2009; Tiso et al., 2009) and is also important in their differentiation
as it can activate MBP transcription as in the mouse (Xin et al., 2005; Li et al.,
2007a).
Due to the importance of olig2 in the generation of both motor neurons
and oligodendrocytes, it has been proposed that these cell types are generated
from the same precursor cell population in the spinal cord. Fate-mapping studies
in the zebrafish demonstrated that oligodendrocytes are generated from the
same olig2-expressing precursors as earlier-derived motor neurons (Park et al.,
2002). Studies in the rodent system also suggest a common lineage-restricted
precursor cell population although it is still under debate (Richardson et al., 1997;
Richardson et al., 2000; Lu et al., 2002; Zhou and Anderson, 2002; Wu et al.,
2006).

Floor plate
The floor plate is a ventral midline structure made of up cuboidal epithelial
cells that extends through the spinal cord, hindbrain, midbrain and posterior
diencephalon (Jessell et al., 1989; Wilson and Houart, 2004). The floor plate has
not yet been identified in the forebrain where patterning is the least understood.
Once the floor plate is specified, it will then begin to express shh (Fig. 3.1) (Marti
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et al., 1995; Roelink et al., 1995; Chiang et al., 1996; Goodrich et al., 1997; Ding
et al., 1998) necessary for the specification for oligodendrocytes as described
above.
In the zebrafish, the floor plate in the spinal cord is three to four cells wide,
comprised of one row of medial floor plate cells flanked by two rows of lateral
floor plate cells (Fig. 3.1), while in the brain, there are six to seven rows
(Odenthal et al., 2000). These different populations of cells can be distinguished
via the expression of specific genes (Placzek et al., 1993; Roelink et al., 1995;
Yamada et al., 1991; Ang et al., 1993; Monaghan et al., 1993; Sasaki and
Hogan, 1993). The shh gene is duplicated in zebrafish, one named shh and the
other twhh (Ekker et al., 1995; Zardoya et al., 1996). They vary in expression
whereby they are both expressed in the medial floor plate but shh is also
expressed in the notochord (Krauss et al., 1993; Ekker et al., 1995; Etheridge et
al., 2001). Along with the shh paralogs, cells of the medial floor plate also
express members of the foxa subfamily of winged-helix/fork head box (fox)
transcription factor genes, fkd4 (foxa), fkd7 (foxa1) (Odenthal and NussleinVolhard, 1998), and axial (foxa2) (Strahle et al., 1993; Odenthal and NussleinVolhard, 1998). In addition to expression in the medial floor plate, cells of the
lateral floor plate also express fkd4 (foxa) and axial (foxa2) (Odenthal et al.,
2000)..
Along with different populations of floor plate cells existing along the
mediolateral axis, there has also been evidence for distinct populations of medial
floor plate cells along the anterioposterior axis. These populations differ
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morphologically and molecularly. They also arise from separate embryonic
origins and require distinctive inductive processes. There has also been evidence
for floor plate cells beyond the caudal diencephalon. It is currently unknown if
these different populations of cells also function differently (Placzek and Briscoe,
2005).

Myelin genes
After OPCs are specified, they proliferate and migrate away from their
restricted locations to populate the brain and spinal cord (Park et al., 2002; Park
et al., 2007; Schebesta and Serluca, 2009; Buckley et al., 2010). Along with
genes regulating oligodendrocyte specification and early stages of differentiation
as mentioned earlier in this chapter, oligodendrocytes also express genes
important for later stages of oligodendrocyte differentiation and myelination
including the mammalian orthologs of mbp, dm20 (plp1b) and p0 (Brosamle and
Halpern, 2002; Buckley et al., 2010).
Expression of these three genes begins at 48hpf in a few cells in the
ventral medial hindbrain and at 72hpf in the spinal cord (Brosamle and Halpern,
2002). By 4dpf, a small number of oligodendrocytes express these genes in the
midbrain while large numbers are positive in the hindbrain along the ventral
hindbrain bundle and in the spinal cord along the ventral midline. In the optic
nerve, expression was detectable by 4dpf in very few oligodendrocytes, while the
number of cells continued to increase by 7dpf and 10dpf (Brosamle and Halpern,
2002).
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mbp is also expressed in Schwann cells of the lateral line system, a
mechanosensory organ of fish and amphibians used to detect motion in the
water (Montgomery et al., 2000). It is composed of two major branches, the
anterior lateral line located on either side of the head and the posterior lateral line
that runs lengthwise down both sides of the trunk and tail (Ma and Raible, 2009).
Mbp was first detected in the posterior lateral line of the trunk at 48hpf, and by
4dpf, mbp was expressed by both the anterior and posterior lateral lines
(Brosamle and Halpern, 2002).
The function of these three genes have not yet been studied in detail but
due to conservation of their predicted protein sequences with the mammalian
sequences and the fact that they are expressed prior to myelination, it is very
likely functions are conserved between zebrafish and mammals (Brosamle and
Halpern, 2002; Buckley et al., 2008; Buckley et al., 2010).
Myelin basic proteins are common to the myelin of nearly all vertebrate
fish and are expressed in the central and peripheral nervous systems. In
zebrafish, the mbp gene may also be alternatively spliced as demonstrated in
mammals but low sequence similarity has made it difficult to relate the sequence
to individual exons of mammalian mbp, but exons I, 3, and part of 4 seem to
exhibit the greatest similarity (Brosamle and Halpern, 2002). Three predicted
variants have been identified thus far (Buckley et al., 2010) but no exon-specific
functions have been characterized.
Mbp mRNA is also localized to oligodendrocyte processes in zebrafish
and sequence analysis revealed a RNA transportation signal in the 3′
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untranslated region of the transcript important for packaging of mbp mRNA to
transport vesicles (Brosamle and Halpern, 2002). mbp mRNA is not transported
into cell processes of the shark (Smith et al., 2001), indicating that this way of
MBP targeting may have evolved later.
Methods have become available for accurate, rapid assessment of relative
levels of myelination in zebrafish by the use of mbp mRNA quantification and
MBP immunohistochemistry, indicating the importance of MBP in myelin of
zebrafish (Buckley et al., 2010).
In addition to MBP, oligodendrocytes express PLP-splice variant DM20.
Fish contain the DM20 variant while tetrapods contain both DM20 and PLP. The
reason for this is because in the beginning of tetrapod evolution after their
divergence from lungfishes, the DM20 gene acquired a splice donor site for
inclusion of exon 3B, which encodes the PLP-specific domain of the third
cytosolic loop (Nave et al., 1987; Schliess and Stoffel, 1991; Yoshida and
Colman, 1996). Zebrafish only express the DM20 isoform of plp (Brosamle and
Halpern, 2002) and there has been conflicting data on whether DM20 can
functionally replace PLP in mammalian central nervous system myelin (Stecca et
al., 2000; Sporkel et al., 2002).
PLP is a member of the lipophilin family which includes two other
members, M6A and M6B (Yan et al., 1993; Gow, 1997). M6a and M6b mRNA is
localized to neurons and not oligodendrocytes (Yan et al., 1993). The
orthologous gene names in fish are DMα (PLP), DMβ (M6A) and DMγ (M6B).
These three genes were duplicated as a result of genome-wide duplication

74

events and named: dmα1, dmα2, dmβ1, dmβ2, dmγ1, dmγ2 (Schweitzer et al.,
2006). The dmα2 gene is the closest relative of mammalian dm20 and is
expressed by oligodendrocytes and present in central nervous system myelin of
fish (Yoshida and Colman, 1996; Brosamle and Halpern, 2002; Schweitzer et al.,
2003; Morris et al., 2004). Many published studies, including chapter 4, refer to
this gene as plp1b instead of dmα2.
PLP’s counterpart in the myelin of the PNS is myelin protein zero (P0), the
most abundant protein in Schwann cells of mammals. P0 is a glycosylated cell
adhesion molecule of the immunoglobulin superfamily (Lemke and Axel, 1985;
Williams and Barclay, 1988) and is important for adhesion and compaction of
extracellular myelin layers in mammals (D'Urso et al., 1990; Filbin et al., 1990;
Schneider-Schaulies et al., 1990; Lanwert and Jeserich, 2001). In
phylogenetically older vertebrate classes, such as fishes, P0 and P0–like protein
genes are expressed in the peripheral nervous system as in mammals, but are
predominantly expressed in the central nervous system which marks one of the
largest biochemical differences between oligodendrocytes in fish versus
mammals (Franz et al., 1981; Lanwert and Jeserich, 2001; Brosamle and
Halpern, 2002; Schweitzer et al., 2003; Schweigreiter et al., 2006; Avila et al.,
2007). Its function has not yet been characterized in the zebrafish but its
adhesive properties have been demonstrated in vitro showing similarity with the
mammalian proteins (Lanwert and Jeserich, 2001).
Since P0 is predominantly expressed by fish oligodendrocytes and PLP is
expressed by mammalian oligodendrocytes, it has been suggested that there
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was likely an evolutionary shift from P0 to PLP in terrestrial vertebrates. The
appearance of PLP was thought to occur after the divergence of bony fishes, and
through millions of years thereafter, while it was still co-expressed with P0, it
underwent a high mutational rate ultimately leading to the evolution of its
function. Shortly after, P0 silently dropped out of central nervous system myelin
(Yoshida and Colman, 1996). Supporting the idea of a P0 to PLP switch in myelin
of the central nervous system, the zebrafish P0 promoter shares greater
sequence homology with the mammalian plp promoter than with the mammalian
p0 promoter (Jeserich et al., 1997; Jeserich et al., 2008) suggesting that they
may be regulated in a similar manner. In support of this idea, the mouse plp
promoter is able to drive expression of enhanced green fluorescent protein in
oligodendrocytes of transgenic zebrafish (Yoshida and Macklin, 2005).
A microarray screen on cells sorted from transgenic zebrafish has recently
identified additional genes expressed by oligodendrocytes, including claudink, a
tight junction associated protein expressed only in oligodendrocytes and
Schwann cells (Takada and Appel, 2010). Its expression timeline is similar to the
one found for mbp as it begins at 48hpf in the ventral medial hindbrain and by
72hpf expression is more prominent in the brain as well as in the anterior and
posterior lateral lines (C. Brösamle, personal communication). No functions have
been reported yet in zebrafish but its related mammalian protein, Claudin11/Osp, is expressed by mammalian oligodendrocytes (Morita et al., 1999) and
Claudin-11 null mice exhibit slowed nerve conduction and hind limb paralysis
(Gow et al., 1999).
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Myelination
After the above-described genes are properly expressed, myelination
occurs in a caudal to rostral fashion in the zebrafish, beginning in the spinal cord
at 3dpf, in the hindbrain at 4dpf and at 7dpf in the optic nerve (Brosamle and
Halpern, 2002; Kirby et al., 2006; Buckley et al., 2010). Myelin compaction
begins at 4dpf in the spinal cord, 7dpf in the hindbrain and by 10dpf in the optic
nerve (Brosamle and Halpern, 2002; Buckley et al., 2010).
Structural similarities are shared between the myelin of zebrafish and
mammals except that the periodicity differs slightly (Avila et al., 2007). The
nodes of Ranvier have similar ultrastructure and protein composition (Woods et
al., 2006; Voas et al., 2007). Thus, the properties of vertebrate myelin are
evolutionarily highly conserved.
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Figure 3.1. Cross section of the developing spinal cord. The floor plate is
composed to two populations of cells: medial floor plate (M) and lateral floor
plate (L). The floor plate is present in the ventral developing spinal cord,
hindbrain, midbrain and posterior diencephalon (spinal cord depicted here) and
lies directly above the notochord (N). It secretes the signaling molecule SHH
which specifies dorsal to ventral fates including motor neurons and
oligodendrocytes from the motor neuron progenitor domain (pMN). Dorsal is to
the top.
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CHAPTER 4
Autotaxin regulates the presence of differentiating oligodendrocytes in the
developing CNS of the zebrafish
(This chapter is in preparation for submission to the Journal of Neuroscience or
Glia. The work reported for this manuscript is based primarily on my own efforts.
Assistance was provided by Dr. James Lister (collaboration and training in
zebrafish-related techniques), Sati Afshari (western blots in Fig 4.4a),
Christopher Waggener (cryosectioning for Fig. 4.2B) and Jessicka Hall (counting
of olig1-positive oligodendrocytes in Fig 4.8c). Due to different conventions
related to the nomenclature of genes, mRNAs and proteins in different species, I
would like to clarify that throughout this manuscript the zebrafish conventions
were used.)

Introduction
Autotaxin (Atx), also referred to as phosphodiesterase I-α/Atx (PDI-α/Atx)
or ENPP2, was originally identified as an autocrine tumor motility stimulating
factor in melanoma cell supernatants (Stracke et al., 1992). The majority of
functions relating to Atx have been attributed to the generation of the lipid
signaling molecule, lysophosphatidic acid (LPA), via Atx’s lysophospholipaseD
(lysoPLD) enzymatic activity (Tokumura et al., 2002; Umezu-Goto et al., 2002).
Atx is secreted by a variety of cell types and has been implicated in both disease
and normal development (Moolenaar et al., 2004; van Meeteren and Moolenaar,
2007; Yuelling and Fuss, 2008; Nakanaga et al., 2010).
One of the cell types that express and secrete Atx are oligodendrocytes,
the myelinating cells of the central nervous system (Fuss et al., 1997; Fox et al.,
2003). Oligodendrocytes develop from oligodendrocyte progenitor cells (OPCs)
that are specified in restricted regions of the central nervous system followed by
extensive proliferation and migration to their prospective destinations throughout
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the brain and spinal cord. In vitro data in rodents indicate that as
oligodendrocytes develop, they undergo coordinated changes in morphology and
gene expression necessary for their differentiation into mature myelinating
oligodendrocytes. During this differentiation process, they transition from having
a bipolar morphology into a cell with a complex network of multiple, branching
processes which will eventually result in the establishment of membranous
structures that wrap axons, if present. As oligodendrocytes differentiate, their
gene expression profile also changes. Transcription factors of the basic helixloop-helix family, Olig1 and Olig2 regulate oligodendrocyte specification and
early differentiation, respectively, while myelin basic protein (Mbp) and proteolipid
protein (Plp) are expressed during later stages of differentiation (Miller, 2002).
Previous studies from our laboratory have demonstrated that Atx and its
product, LPA, are involved in regulating the differentiation of oligodendrocytes
(Fuss et al., 1997; Fox et al., 2003; Fox et al., 2004; Dennis et al., 2008; Nogaroli
et al., 2009). More specifically, our previous in vitro data suggest that LPA, likely
generated via Atx’s lysoPLD enzymatic site, regulates the expression of mbp and
formation of membranous structures, while a newly identified functional domain
of ATX, the MORFO domain (modulator of oligodendrocyte remodeling and focal
adhesion organization) facilitates process remodeling and the development of a
complex process network (Fox et al., 2003; Dennis et al., 2008; Nogaroli et al.,
2009). In order for oligodendrocytes to develop into fully mature, functionally
myelinating cells, they must undergo timely changes in both gene expression and
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morphology. Atx, regulating both of these processes, has been identified as an
important molecular player during oligodendrocyte development.
The results obtained in our previous studies were found using an in vitro
paradigm. Thus, Atx’s role in regulating oligodendrocyte development in vivo is
still unresolved. Knockout mice for Atx die at midgestation due to severe vascular
defects in the yolk and embryo proper (Tanaka et al., 2006; van Meeteren et al.,
2006) preventing the study of later processes such as oligodendrocyte
development and myelination.
Zebrafish are a powerful in vivo model in genetics and developmental
biology and can be used for a large range of applications related to human
disease (Lieschke and Currie, 2007). High fertility, rapidly developing and
transparent embryos as well as external fertilization allow for easy manipulation
and observation of many developmental processes including oligodendrocyte
development and myelination in the central nervous system. Oligodendrocyte
specification, differentiation and myelination, as well as many of the genes
regulating these processes, have been found to be evolutionarily conserved in all
vertebrates analyzed thus far, including zebrafish (Brosamle and Halpern, 2002;
Park et al., 2002; Park et al., 2004; Kirby et al., 2006; Woods et al., 2006; Avila et
al., 2007; Li et al., 2007a; Voas et al., 2007; Buckley et al., 2008; Buckley et al.,
2010). Thus, zebrafish provide an excellent model to investigate the in vivo role
of Atx for oligodendrocyte development. In addition, zebrafish can overcome
potential vascular defects as those reported to occur in atx knockout mice
because of their ability to survive for up to seven days without a functional
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vascular system (Ny et al., 2006). This time frame of independence from a fully
functional vascular system is sufficient for investigating oligodendrocyte
development, which occurs within the first three to four days of development
(Brosamle and Halpern, 2002; Park et al., 2002; Kirby et al., 2006; Schebesta
and Serluca, 2009; Buckley et al., 2010).
In this study, we have identified the zebrafish ortholog to mammalian atx
and characterized its expression pattern in the developing zebrafish. Using
morpholino-mediated knockdown of Atx, we discovered a novel functional role for
Atx during early stages of oligodendrocyte development and by doing so, have
demonstrated for the first time that Atx is important for oligodendrocyte
development in vivo. We also found that Atx can regulate later stages of
differentiation in agreement with our previous in vitro studies. The results
presented here therefore indicate that ATX is necessary for both early and late
stages of oligodendrocyte development

Materials and Methods
Zebrafish strains and care
Embryos of the wild type AB strain were obtained through natural matings,
raised at 28.5 °C or 24 °C, and staged according to morphological criteria and
hours post fertilization (hpf) (Kimmel et al., 1995). To prevent pigmentation,
embryos were raised in egg water and treated with 0.003% phenylthiourea after
gastrulation.
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Sequence analysis
Due to different conventions related to the nomenclature of genes,
mRNAs and proteins in different species, we would like to clarify that throughout
this manuscript the zebrafish conventions were used. Sequence data for atx
were originally obtained by BLAST searches on the NCBI database (Sayers et
al., 2009). Amino acid alignments and phylogenic tree analyses were performed
using the Vector NTI software package (Invitrogen, Carlsbad, CA).

Cloning of cDNAs
For the atx in situ probe, a partial coding sequence was obtained using
Not1 and EcoR1 restriction sites from the ATX ORF (clone ID 3816628; Open
Biosystems, Huntsville, AL) and cloned into the pBS vector. For cloning of a
partial coding sequence of olig1 for an in situ probe, we performed RT-PCR on
RNA isolated from 3dpf embryos using the following primers: forward (5’ATACAGAGAGCAGGGCGAAA-3’), reverse (5’-AAACGCATGGCTGGATTAAC3’) and cloned the PCR product into the pBS vector. An in situ probe for twhh
was obtained with PCR amplification of the partial coding sequence in the pDNRLIB vector (ATCC, Manassas, Va) with the following primers: forward (5’TGGATAACCGTATTACCGCC-3’), reverse (5’CGCGCAATTAACCCTCACTAAAGCACTAGTCATACCAGGATC-3’).
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in situ hybridization
Digoxigenin- or fluorescein-labeled anti-sense cRNA probes were
synthesized using T3 or T7 RNA polymerase. The following cRNA probes were
used: atx, mbp (Brosamle and Halpern, 2002), olig1, foxa1 (Odenthal and
Nusslein-Volhard, 1998), foxa2 (Strahle et al., 1993) and twhh (ATCC,
Manassas, VA). In situ hybridizations were performed as previously described
(Thisse and Thisse, 2008) with the following modification: embryos were
permeabilized in proteinase K at 5ug/mL for 0.5min per hpf at 37°C followed by
additional permeabilization in acetone for 8 minutes at -20C. For colorimetric in
situ hybridizations, digoxigenin-labeled cRNA probes were used and bound
cRNAs were detected using alkaline phosphatase-conjugated anti-digoxigenin
antibodies and NBT/BCIP (Roche Diagnostics, Indianapolis, IN) as substrate.
Dual fluorescent in situ hybridizations were conducted using digoxigeninand fluorescein-labeled cRNA probes. Bound cRNA probes were detected using
peroxidase-conjugated anti-digoxigenin or anti-fluorescein antibodies (Roche
Diagnostics, Indianapolis, IN) in combination with tyramide fluorochrome (Cy3 or
Fluorescein) derivatives (Perkin Elmer, Waltham, MA) as previously described
(Julich et al., 2005; Brend and Holley, 2009). The following parameters were
modified: embryos were permeabilized in 10ug/mL proteinase K for 30min at RT
and were not dehydrated in between antibody incubations.
After in situ RNA hybridization, embryos were either imaged as whole
mounts or cryosectioned. Embryos for sectioning were sucrose cryoprotected
(30% sucrose/PBS), embedded in Tissue-Tek O.C.T. compound (Sakura
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Finetek, Torrance, CA), then frozen and stored at −80°C until use. Cryostat
sections (20 μm) were obtained with a Shandon cryostat microtome (GMI,
Ramsey, MN). Embryos and sections of colorimetric in situ hybridizations were
mounted in 90% glycerol/PBS, while fluorescent in situs were mounted in
Vectashield® mounting medium (Vector laboratories, Burlingame, CA).

Immunohistochemistry
Zebrafish embryos were permeabilized using 0.25% trypsin in PBS/0.1%
Tween-20 then blocked in 10% normal goat serum in PBS/0.1% Tween-20.
Embryos were then incubated with primary antibodies: anti-acetylated α-tubulin
(1:1000; Sigma-Aldrich, St. Louis, MO) or anti-caspase (1:50; BD Biosciences,
Franklin Lakes, NJ) in blocking buffer overnight at 4°C. Secondary antibodies
used were goat anti-mouse Alexa 488 (for anti-acetylated α-tubulin; Invitrogen,
Carlsbad, CA) or goat-anti-rabbit Alexa 568 (for anti-caspase; Invitrogen,
Carlsbad, CA).

Image analysis
Embryos and sections of colorimetric in situ hybridizations were mounted
in 90% glycerol/PBS. Whole mount images were acquired on an Axio Observer
Z.1 microscope or a Discovery.V20 stereoscope with an AxioCam MRc camera
using the extended focus module of the axiovision software package (Carl Zeiss
MicroImaging, Inc., Thornwood, NY). Images of MBP stained embryos were
acquired on an Olympus SZX12 stereomicroscope with a DP70 digital camera

86

(Olympus, Center Valley, PA). Fluorescent in situ hybridized and antibody
stained embryos were mounted in Vectashield® mounting medium (Vector
laboratories, Burlingame, CA). Images were obtained using confocal laser
scanning microscopy (TCS SP2 AOBS, Leica Microsystems, Exton, PA or LSM
510 META, Carl Zeiss MicroImaging, Inc., Thornwood, NY). Once captured,
images were imported into Adobe Photoshop and adjustments were limited to
contrast, levels, color matching settings and cropping.
Olig1-positive cell numbers were determined using the particle count
plugin (Wright Cell Imaging Facility) to the ImageJ software package (Abramoff et
al., 2004). Cells expressing mbp mRNA were visualized with a dissecting
microscope and manually counted. Numbers of cells stained for olig1 and mbp
in the brain were counted, averaged and set as percentage of control.

Morpholino injections
Morpholino anti-sense oligonucleotides (MOs) were designed and
synthesized by GeneTools (Philomath, OR) in accordance with the published
zebrafish genome data (ensemble entry ENSDART00000047920). Two atx MOs
were used: Translation blocking (5’-TGCGTCTGGTGGCTCTCTTCCACAC-3’)
and splice-blocking (5’-AAGAAGCATCCTACTTTTTGAGAGC-3’). As controls, 5
base pair mismatch MOs were used: translation blocking control: (5’TGCGTGTGGTGCCTGTCTTGCAGAC-3’) and splice-blocking control: (5’AACAAGGATCGTACTTTTTGACACC-3’). MOs were reconstituted in ddH2O
and quantified by fiber optic spectrophotometry using the Nanodrop ND-1000
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(Nanodrop Inc., Wilmington, DE) as previously described (Arbogast, 2007). MOs
were then diluted in Danieau buffer (Westerfield, 1993) and 1nL was injected at
the 1 to 4-cell stage. The atx translation-blocking MO and its control were
injected at a concentration of 1mg/mL, while the atx splice-blocking MO and its
control were used at a concentration of 10mg/mL.

Western blot analysis
Embryos were deyolked as previously described (Westerfield, 2000).
Briefly, embryos were anesthetized with Tricaine, resuspended in cold Ringer’s
solution containing 1mM EDTA and cOmplete mini protease inhibitor cocktail
(Roche Diagnostics, Indianapolis, IN) and triturated with a 1-200μL pipette tip.
Embryos were washed twice in Ringer’s solution, homogenized in 40mM
HEPES; 40mM NaCl; 10mM EDTA; 1% Triton; 0.1% SDS with cOmplete mini
protease inhibitor cocktail and centrifuged at 10,000rpm for 3 min. Supernatants
were collected and used for further analysis
Supernatants of whole, deyolked embryos were separated on 7.5%
precast acrylamide gels (MiniProtean TGX precast gel; BioRad, Hercules, CA),
and proteins were transferred onto immobilon-P membranes (Millipore, Billerica,
MA). Membranes were blocked in 5% milk/PBS/0.1% Tween-20 for 30 min and
incubated with primary antibodies overnight at 4°C. The following antibodies
were used: zebrafish-specific anti-Atx (1:750; EZBiolab, Carmel, IN) and antiactin (1:500; Sigma-Aldrich, St. Louis, MO). The zebrafish-specific anti-Atx
antibody was generated against a peptide by EZbiolab and is not available
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commercially. In antibody blocking experiments, anti-ATX antibodies were
preincubated in a 1:2 dilution of antigenic peptide for 30 min. For detection of
bound primary antibodies, membranes were incubated with a HRP-conjugated
goat anti-rabbit IgG secondary antibody (1:10,000; Vector Laboratories,
Burlingame, CA) for 30 min. Bound antibody complexes were detected using
Amersham ECL plus western blot detection reagents (GE Healthcare,
Piscataway, NJ). Chemiluminescent signals were detected using a Futura 2000K
developer (Fisher Scientific, Pittsburgh, PA). For densitometric analysis the
ImageJ software package was used (Abramoff et al., 2004).

qRT-PCR
Total RNA was isolated from embryos using Trizol (Invitrogen, Carlsbad,
CA) and RNA samples were treated with DNase using the DNA-Free kit (Applied
Biosystems, Austin, TX). RNA was quantified by fiber optic spectrophotometry
using the Nanodrop ND-1000 (Nanodrop Inc., Wilmington, DE). For qRT-PCR,
oligo (dT)-primed cDNAs were synthesized using the Superscript II RT kit
(Invitrogen, Carlsbad, CA). PCR was performed on a Chromo 4 Four-Color
Real-Time or a CFX96 system (BioRad, Hercules, CA) using the iQ SYBR Green
Supermix (BioRad, Hercules, CA). The following primer pairs were used at an
annealing temperature of 58°C: mbp (Buckley et al., 2010); plp1b: forward (5’TGCCATGCCAGGGGTTGTTTGTGGA-3’), reverse (5’
TGGCGACCATGTAAACGAACAGGGC-3’); cldnk: forward (5’TGGCATTTCGGCTCAAGCTCTGGA-3’), reverse (5’-
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GGTACAGACTGGGCAATGGACCTGA-3’); olig1: forward: (5’CCGGTGTAGGGGGAGCACTGCA-3’), reverse (5‘TCCGAGCCAGCACCAGTGTCGAG-3’). β-actin (Buckley et al., 2010) and
EF1α: forward (5’-GTACTACTCTTCTTGATGCCC-3’), reverse (5’GTACAGTTCCAATACCTCCA-3’) were also amplified and their geometric
averages were used for normalization (Vandesompele et al., 2002).
PCR conditions were as follows: 95°C for 3 min followed by 39 cycles at
94°C for 15 s, annealing temperature for 20 s, and 72°C for 20 s. For relative
comparison of mbp, olig1, plp1b and cldnk mRNA levels present in atx TL MO or
atx E2I2 MO-treated embryos compared to their respective controls, the ΔΔCT
method was used (Livak and Schmittgen, 2001).

Results
Atx is expressed in the zebrafish
The expression of atx has been described in a number of vertebrate
species, including human, rat, mouse, chicken and frog, thus suggesting that atx
represents an evolutionary conserved gene in vertebrates including the zebrafish
(Murata et al., 1994; Narita et al., 1994; Bachner et al., 1999; Ohuchi et al., 2007;
Masse et al., 2010). To identify the atx ortholog in zebrafish, BLAST searches
were performed using the zebrafish genome database (http://www.zfin.org) and
the rat and human atx mRNA sequences. A single entry (NM_200603.1) with
high homology to the existing atx sequences was identified (Fig. 4.1). The
sequence identity of zebrafish atx with its orthologs is similar to what has been
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described for other zebrafish genes (Brosamle and Halpern, 2002). Amino acid
sequence alignments further confirmed the presence of conserved functional
domains within zebrafish Atx, including the enzymatically active lysoPLD site that
is critically dependent on the presence of the tyrosine residue located at position
210 in the human sequence (Fig. 4.1C; (Clair et al., 1997; Gijsbers et al., 2003;
Koh et al., 2003; Masse et al., 2010).
The human and mouse atx genes span 27 exons and give rise to three
known protein isoforms, Atxα, Atxβ and Atxγ, due to alternative splicing of exons
12 and 21 (Giganti et al., 2008). Out of the known Atx protein isoforms, Atxβ,
which lacks exons 12 and 21, appears to be the evolutionary oldest form, since it
is present in all species so far characterized. Atxγ has been identified in the rat
but not in chicken or zebrafish (data not shown and (Narita et al., 1994; Fuss et
al., 1997).
In the teleost fish lineage, whole-genome duplication occurred subsequent
to its divergence from mammals, thus generating co-orthologs to many single
mammalian genes (Ohno, 1970; Taylor et al., 2003; Postlethwait et al., 2004).
Two zebrafish atx genes with almost identical coding sequences with 99.6%
identity have so far been identified. These two atx genes are located next to each
other, and they are transcribed in the same direction. Due to the fact that both
genes are located right next to each other and not on different linkage groups,
they are likely a result of a tandem rather than a large scale genome duplication
event.
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To assess the extent to which atx is expressed in the developing zebrafish
in a similar pattern as described for the other vertebrate species, we performed in
situ hybridizations. In these studies, atx mRNA was first detected at 36hpf. At all
developmental stages analyzed (36-72hpf), atx mRNA was found to be present
in the pectoral fin buds, the anterior pharyngeal arches (mandibular and hyoid)
and the developing vasculature (posterior cardinal vein and head vessels) (Fig.
4.2A). Up to 72hpf, atx mRNA was additionally found in the hypochord and the
cephalic floor plate. Both of these are transient structures that are no longer
present at older ages (Altman and Bayer, 1984; Eriksson and Lofberg, 2000).
Furthermore, atx mRNA could be detected in the posterior lateral line with mRNA
levels decreasing with age. From lateral views, atx mRNA was also detectable in
a structure resembling the trabecula cranii, a component of the neurocranium.
Atx mRNA localization in the developing vasculature and the cephalic floor plate
was further confirmed by comparative in situ hybridization using cRNA probes to
genes known to be expressed in the vasculature (fli1a) or the floor plate (foxa1,
foxa2 and twhh) (Brown et al., 2000) (data not shown and Fig. 4.2B).
Detailed atx expression profiles during development have so far only been
described for mouse, chick and frog (Bachner et al., 1999; Ohuchi et al., 2007;
Masse et al., 2010). In these studies and similar to the zebrafish, atx was found
expressed in the developing extremities (fin or limb buds) and jaw (pharyngeal
arches). Atx expression in the developing vasculature, however, appears to be a
feature restricted to lower vertebrates, the chick, frog and zebrafish.
Nonetheless, Atx has been functionally implicated in regulating blood vessel
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formation during development in the mouse. Thus, despite differences in the
pattern of expression, Atx likely plays a functionally conserved role in regulating
the formation and/or maintenance of the vasculature. Atx expression in the floor
plate and/or ventral spinal cord was observed in all species analyzed with the
exception of the chick. So far, the only structure in which atx appears to be
expressed in a zebrafish-unique fashion is the hypochord, a structure that only
exists in anamniotes and that has no homolog in mammals.
Taken together, the above data demonstrate that atx is a gene whose
sequence is evolutionarily conserved within vertebrates. In addition, conserved
features can be identified in atx’s developmental expression pattern. Thus, it is
likely that ATX’s functional properties are, at least in part, also evolutionarily
conserved within vertebrates.

atx is expressed by differentiating oligodendrocytes in the developing
zebrafish
Our previous studies identified ATX as a protein that is expressed and
released by developing oligodendrocytes during the developmental period of
active myelination (Fuss et al., 1997; Fox et al., 2003). Active myelination in the
zebrafish has been described to occur between 48hpf and 96hpf in the
developing hindbrain (Brosamle and Halpern, 2002; Buckley et al., 2010). Thus,
to assess the extent to which atx is expressed by differentiating
oligodendrocytes, we performed double-fluorescent in situ hybridizations of
zebrafish embryos staged at 72hpf, a time point at which premyelinating and
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actively myelinating oligodendrocytes are present, and atx was found expressed
in the hindbrain (Fig. 4.2). To be able to unequivocally identify differentiating
oligodendrocytes, we used cRNA probes specific for mbp and plp1b (Brosamle
and Halpern, 2002). As shown in Fig. 4.3., plp1b-positive cells located in the
developing hindbrain were also positive for atx. Similar results were obtained for
mbp-positive cells (data not shown). Interestingly, we could not detect expression
of atx in either mbp- or plp1b-positive cells at 60hpf, suggesting that atx
expression may be restricted to the later stages of the oligodendrocyte lineage or
very low and thus below the detection limit at the earlier stages analyzed.
The above data demonstrate that at least in the developing hindbrain of
the zebrafish oligodendrocytes, similar to what has been observed in the rat,
express atx during a time period when active myelination occurs.

Down-regulation of atx expression inhibits and/or delays the appearance of
mbp-positive oligodendrocytes in the developing zebrafish hindbrain
without significantly affecting the establishment and/or maintenance of
axonal tracts
In vitro studies from our laboratory demonstrated that atx’s expression by
differentiating oligodendrocytes is important for coordinating their timely
development (Fuss et al., 1997; Fox et al., 2003; Fox et al., 2004; Dennis et al.,
2005; Dennis et al., 2008; Yuelling and Fuss, 2008; Nogaroli et al., 2009). To
determine the extent to which atx expression may be regulating oligodendrocyte
development in vivo in the zebrafish, a translation-blocking morpholino (atx TL
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MO) was used to knock-down atx expression. To assess the efficiency of this
morpholino, western blot analyses were performed. As shown in Fig. 4.4A,
injection of the atx TL MO resulted in reduced Atx protein levels. Interestingly,
antibodies against zebrafish Atx recognized two molecular weight forms in whole
zebrafish homogenates. The appearance of both molecular weight forms can be
inhibited by pre-incubation with the peptide used to generate the zebrafishspecific antibodies. The nature of these two molecular weight forms is not entirely
clear. It is most likely that they reflect differences in posttranslational
modifications, such as glycosylations (Pradere et al., 2007). Both forms were
included for quantification via densitometry.
After having verified that injection of the atx TL MO leads to significantly
decreased Atx protein levels, developing zebrafish embryos staged at 66hpf
were assessed for the presence of differentiating oligodendrocytes. For this
purpose, in situ hybridizations using a cRNA probe specific for mbp were
performed. As shown in Fig. 4.5A-C and F, there was a significantly reduced
number of mbp-positive cells detectable in the hindbrain of atx TL MO-injected
zebrafish embryos. This effect on the presence of mbp-positive cells in the CNS
was much more dramatic than any effect noticed in the PNS. To further confirm
the specificity of the effect of a reduction in atx expression on the timely
appearance of mbp-positive cells, a splice blocking morpholino was used (atx
E2I2 MO). RT-PCR analysis demonstrated that injection of the atx E2I2 MO led
to an altered splice pattern and efficient elimination of atx’s exon 2. The control
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MO did not have such an effect (Fig. 4.4B). Elimination of exon 2 leads to
premature termination of translation, due to the creation of a frame shift stop
codon, and thus to reduced levels of full length Atx. As shown in Fig. 4.5.E,
injection of the atx E2I2 MO led to a similar reduction in the number of zebrafish
embryos expressing normal (untreated) levels of mbp mRNA as seen for the atx
TL MO. To further substantiate these data, quantitative RT-PCR analysis was
performed. As shown in Fig. 4.5G and E, injection of either atx MO led to a
significant reduction in the levels of mbp RNA.
Due to the presence of early CNS defects in atx knock-out mice (Tanaka
et al., 2006; van Meeteren et al., 2006; Fotopoulou et al., 2010), we wanted to
ensure that the observed effects on oligodendrocytes were not secondary to
gross effects on the axonal network. To assess the integrity of axonal
projections, control and atx TL MO-injected embryos were immunostained with
an anti-acetylated α-tubulin antibody. No significant differences were noted (Fig.
4.6).
Taken together, these data demonstrate that a reduction in the expression
of atx inhibits and/or delays the appearance of mbp-positive oligodendrocytes in
the developing zebrafish hindbrain without significantly affecting the
establishment and/or maintenance of axonal tracts.
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Down-regulation of atx expression inhibits and/or delays the appearance of
the later stages of the oligodendrocyte lineage in the developing zebrafish
hindbrain
The reduced number of mbp-positive cells seen upon atx MO injection
could either be due to a specific effect on mbp expression or to an
inhibition/delay of oligodendrocyte differentiation. To address this question, we
performed in situ hybridizations using cRNA probes specific for two additional
genes known to be expressed by differentiating oligodendrocytes just prior to or
during myelination, namely plp1b and claudinK (Brosamle and Halpern, 2002;
Takada and Appel, 2010). Injection of either atx MO led to a decrease in both
plp1b and claudinK mRNA levels.
These data indicate that in the developing zebrafish hindbrain atx is an
important regulator of oligodendrocyte differentiation at least at the later stages of
the lineage.

Down-regulation of atx expression inhibits and/or delays the appearance of
very early stages of the oligodendrocyte lineage in the developing
zebrafish hindbrain
The above findings related to a role of Atx in regulating the differentiation
of later stages of the oligodendrocyte lineage, similar to what has been described
for differentiating rodent oligodendrocytes in culture (Nogaroli et al., 2009). In the
cell culture studies, the effect of Atx was mediated by an autocrine mechanism
via the secretion of Atx by differentiating oligodendrocytes. It is thus likely that
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such an autocrine mechanism also contributes to the effects seen in the
zebrafish. However, prior to the time of analysis, namely 66hpf, zebrafish
oligodendrocytes appear to only express very low levels of atx. The major source
of Atx release into the hindbrain at these earlier ages is the cephalic floorplate.
Thus, Atx may be present in the developing hindbrain at very early stages during
oligodendrocyte development. To assess the extent to which such an early
developmental presence of Atx may influence oligodendrocyte differentiation, in
situ hybridizations were performed using a cRNA probe specific for one of the
earliest known genes specifically expressed in cells of the oligodendrocyte
lineage in the zebrafish (Li et al., 2007a; Schebesta and Serluca, 2009). As
shown in Fig. 4.8, upon injection of the atx TL MO the number of olig1-positive
cells was found significantly reduced in the hindbrain of the developing zebrafish.
Similarly, olig1 mRNA levels were significantly lower compared to controls. This
reduction in the number of olig1-positive cells was not found associated with a
drastic increase in cell death as assessed by the presence of activated caspase
3 (data not shown).
Taken together, these data demonstrate that Atx in vivo in the developing
zebrafish regulates the differentiation and/or specification of early stages of the
oligodendrocyte lineage. In addition, our data suggest that this novel role of Atx
during early oligodendrocyte development occurs by a paracrine mechanism via
the secretion of Atx by cells of the cephalic floor plate.
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Discussion
The data presented here demonstrate that atx is expressed in the
zebrafish in a similar pattern as seen in other vertebrates and is necessary for
regulating the later stages of oligodendrocyte development confirming our in vitro
data (Nogaroli et al., 2009). We have also identified a novel function of ATX
during early stages of oligodendrocyte development when specification and early
differentiation is occurring.
Our expression analysis is the first complete developmental study of atx
expression in the zebrafish embryo. Similar developmental studies have been
conducted in mouse, chick and frog (Bachner et al., 1999; Ohuchi et al., 2007;
Masse et al., 2010) reporting similar expression patterns and confirming
evolutionary conservation of atx’s expression pattern. Expression of atx in the
floor plate is consistent with the mouse and potentially the frog where they
describe expression in the ventral spinal cord (Bachner et al., 1999; Ohuchi et
al., 2007; Masse et al., 2010). Before this study, atx expression by
oligodendrocytes has only been reported for rodents (Fuss et al., 1997; Fox et
al., 2003).
In the search for the function of Atx in vivo, ubiquitous deletion of atx in
mice led to embryonic lethality due to vascular defects (Tanaka et al., 2006; van
Meeteren et al., 2006; Fotopoulou et al., 2010). Before their death, atx-null mice
display early central nervous system defects including failure of neural tube
closure and increased cell death while heterozygous mice showed no phenotypic
abnormalities (Fotopoulou et al., 2010). In order to study oligodendrocyte
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developmental processes without affecting overall zebrafish development,
especially central nervous system abnormalities, careful titration of our
morpholinos was necessary. Titration of the morpholinos resulted in a reduction
in Atx levels to 50% of control, which was sufficient for studying oligodendrocyte
development in this system without major central nervous system defects. In
agreement with this observation, phenotypically normal heterozygous mice have
50% Atx protein levels at least in the blood (van Meeteren et al., 2006) and our
previous in vitro observations were also observed under conditions with 50% Atx
protein levels (Nogaroli et al., 2009) indicating that functions of Atx during
oligodendrocyte development do not require complete down-regulation of the
protein allowing our analyses to be conducted without major gross abnormalities.
Upon down-regulation of Atx, we observed embryos with less olig1expressing oligodendrocytes compared to controls. olig1 is expressed by
oligodendrocytes early during their development, shortly after they are specified,
preceded by the expression of olig2 (Park et al., 2002; Li et al., 2007a;
Schebesta and Serluca, 2009). In order for oligodendrocytes to perform their
ultimate function in myelination, they must first be specified at appropriate times
then undergo tightly controlled, distinct stages of differentiation. It is unclear at
this time what mechanisms are affected resulting in the phenotype observed
here, but it is possible that the numbers of oligodendrocytes are reduced due to
deficits in oligodendrocyte specification or proliferation. LPA has been shown to
induce differentiation of oligodendrocytes from neuroepithelial precursor cells
(Cui and Qiao, 2007) and proliferation in cell types other than oligodendrocytes
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(Li et al., 2003; Yan et al., 2003; Shano et al., 2008). Signals released from the
floor plate, including the glycoprotein SHH as described in chapter three, have
the ability to regulate the expression of transcription factors important for the
specification and differentiation of oligodendrocytes including olig1 and olig2
which are necessary for oligodendrocyte specification and differentiation,
respectively (Park et al., 2002; Schebesta and Serluca, 2009). It was found in the
mouse that ATX cannot regulate shh expression (Fotopoulou et al., 2010)
making it unlikely to occur in the zebrafish and indicating that the changes we
see are not indirectly due to a modulation of shh expression. In further support of
this idea, atx is expressed in the floor plate during the time when
oligodendrocytes are being specified and during their early development (Park et
al., 2002; Schebesta and Serluca, 2009).
mRNA levels of the later stage oligodendrocyte markers, mbp, plp1b and
cldnk were also found to be reduced along with olig1. In order to determine if the
reduction in later stage mRNA levels were a result of Atx affecting later stages of
differentiation or simply a result of fewer olig1-positive oligodendrocytes, we
counted the number of mbp-positive oligodendrocytes. We found significantly
fewer mbp-positive oligodendrocytes in relation to the number of olig1-positive
oligodendrocytes when Atx levels were reduced. This indicates that the reduced
number of mbp-positive oligodendrocytes is not solely a result of the reduction in
olig1-positive oligodendrocytes, but because of Atx affecting mbp expression
during later stages of differentiation, which is in agreement with our previous in
vitro studies described in chapter two (Nogaroli et al., 2009). Despite the
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differences observed in olig1- and mbp-oligodendrocyte cell numbers, we did not
see differences in their mRNA levels. This is likely because Atx may also affect
mbp expression in Schwann cells. Unfortunately, we were unable to count the
number of mbp-positive Schwann cells in order to figure out this discrepancy
because individual cells cannot be visualized at the time of our analysis.
Expression of mbp by Schwann cells could therefore be masking the actual
mRNA levels expressed in oligodendrocytes leading to no differences between
mbp and olig1 overall mRNA levels. Since cldnk is also expressed by both
oligodendrocytes and Schwann cells (Takada and Appel, 2010), we would then
suspect the same reduction in cldnk cell numbers. Plp1b mRNA levels were also
not significantly different than olig1 levels and because plp1b is only expressed
by oligodendrocytes (Brosamle and Halpern, 2002), Atx down-regulation did not
affect its expression suggesting that Atx may mediate the expression of specific
genes.
The role for Atx in regulating mbp expression during zebrafish
oligodendrocyte development is likely attributable to LPA generated from Atx’s
lysoPLD enzymatic site and not the recently identified MORFO domain (Dennis
et al., 2008) based on our previous in vitro data (Nogaroli et al., 2009) and
unpublished findings from our laboratory. LPA receptors are expressed by
oligodendrocytes in the rodent (Stankoff et al., 2002; Nogaroli et al., 2009) and
so far, one LPA receptor (LPA1) has been identified in the zebrafish (Lee et al.,
2008). Whether LPA receptors are expressed in oligodendrocytes of the
zebrafish and if LPA directly functions in this system has yet to be determined.
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Expression of mbp has been shown to be a reliable method for quantifying
myelin as well as myelination (Buckley et al., 2010). The decreased mbp mRNA
levels observed upon down-regulation of Atx could potentially have functional
consequences on myelination. We have not investigated whether reduced Atx
levels will ultimately affect the myelination process. The timing of myelination
(Brosamle and Halpern, 2002; Buckley et al., 2010) occurs near the outer limits
of morpholino functionality. Thus, it may not be possible to investigate Atx’s role
on myelination with the methods available at this time.
atx expression in the floor plate begins to diminish when expression by
oligodendrocytes begins. This could indicate a “switch” in expression between
the floor plate and oligodendrocytes. As oligodendrocytes mature, they migrate
away from the floor plate to populate the brain and spinal cord. Due to the
distance that differentiating oligodendrocytes reside from the floor plate, and
because the floor plate is a transient structure (Altman and Bayer, 1984), it may
be crucial that oligodendrocytes generate atx themselves in order to promote
their further differentiation. The use of new methods, such as caged morpholinos
(Deiters et al., 2010), which have the ability to allow for temporal regulation of
gene down-regulation, could aid in looking further into ATX’s role during later
stages of differentiation as a more comparable study to the in vitro data
described in chapter two (Nogaroli et al., 2009).
All of the effects reported in this study are likely due to reduced expression
of atx located in the floor plate, before we could detect expression in
oligodendrocytes, indicating that Atx-mediated regulation may be via a paracrine
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mechanism and not solely by an autocrine mechanism as previously thought by
us and others (Stracke et al., 1992; Fuss et al., 1997; Fox et al., 2003; Fox et al.,
2004; Dennis et al., 2008; Nogaroli et al., 2009). We cannot rule out the
possibility that an autocrine mechanism is also involved during this time due to
limits of the detection methods in oligodendrocytes. This is therefore the first
study to suggest that Atx secreted from a separate non-oligodendroglial source
regulates in particular the early stages of oligodendrocyte development.
Taken together, the data presented in this manuscript suggest that Atx is
crucial for the timely appearance of differentiating oligodendrocytes prior to them
becoming myelinating cells. Atx regulates this process during early stages of
their development and continues to have a regulatory role through later stages of
their development. Future studies will be necessary to dissect the exact
mechanisms by which Atx regulates the biology of cells of the oligodendrocyte
lineage.
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Figure 4.1. Zebrafish ATX amino acid identity is conserved with human, rat,
mouse and chick ATX. Sequences were obtained from the NCBI, ensembl or
ZFIN database and cluster-aligned using the AlignX Software module of the
Vector NTI software package (Invitrogen, Carlsbad, CA). (A and B). Phylogenetic
tree and amino acid sequence identity percentages. (C) Amino acid sequence
alignment. All letters are black and are distinguished by background color.
Amino acids identical in all sequences are represented in yellow. The degree of
conservation is color coded (light blue>magenta>white). Blocks of similar amino
acids are represented in green. The T residue required for enzymatic activity, is
marked by white letters on a dark blue background. The lyso-phospholipase Dactive site is single underlined; nuclease-like domain is double-underlined, the
MORFO domain overlaps with the nuclease domain and extra amino acids in
MORFO are indicated by a dotted line. The somatomedin B domains are marked
by a wavy line.
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Figure 4.2. atx is expressed in the anterior pharyngeal arches, developing
vasculature, hypochord, trabecula cranii and cephalic floor plate in the
developing zebrafish. Whole mount in situ hybridization was conducted on
embryos at various developmental stages. (A) Developmental expression of ATX
in embryos staged at 36hpf, 48hpf, 60hpf and 72hpf. Left panel of pictures are
lateral views, anterior is to the right. Right panel of pictures are dorsal views;
anterior is to the top. Scale bar: 100μm. (B) Expression of ATX compared to
cephalic floor plate markers at 48hpf. Dorsal is to the top. Scale bar: 50μm.
Abbreviations: cfp, cephalic floor plate; h, hypochord; ha, hyoid arch; hv, head
vessels; ma, mandibular arch; pcv, posterior cardinal vein; pf, pectoral fin buds;
pll, posterior lateral line; tr, trabecula cranii.
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Figure 4.3. ATX is expressed by differentiating oligodendrocytes in the
ventral hindbrain. Double-fluorescent whole mount in situ hybridization using
probes specific for atx and plp1b was performed using embryos at 72hpf.
Transverse sections are shown; dorsal is to the top. Arrows indicate expression
of atx and plp1b in the same two cells. Images were obtained by confocal
microscopy and represent 2D projections of stacks of 0.488 μm optical sections.
Dorsal is to the top. Scale bar: 20 μm.
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Figure 4.4. Antisense morpholinos designed against ATX successfully
inhibit translation of atx or splicing of atx pre-mRNA. Embryos were injected
with morpholinos designed against translation of ATX (atx TL MO) and premRNA splicing (atx E2I2 MO) along with their respective 5-base pair mismatch
controls (Control). (A) Western blots of 66hpf embryo homogenates were
probed with a zebrafish-specific anti-ATX antibody and β-actin for normalization.
Bar graphs depicting densitometry analysis of ATX protein bands normalized to
β-actin are shown as percent of control (control = 100%). A representative
Western blot is shown. (B). RT-PCR analysis of mRNA from control and atx E2I2
MO-treated embryos at 66hpf. A representative DNA gel and picture depicting
exons and location of primers are shown. Abbrev. E, exon; P, primer.
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Figure 4.5. Reduction of ATX expression leads to a reduction in the
appearance of mbp-positive oligodendrocytes. Embryos were injected with
atx TL, atx E2I2 MOs or their respective controls and staged to 66hpf. (A-C)
Whole mount in situ hybridization using an RNA probe specific to myelin basic
protein (mbp). Representative examples of control (A) and atx TL MO (B-C)
embryos are shown. MBP expression phenotypes in the hindbrain were
classified as normal (A), reduced (B) or absent (C) (arrows). No apparent
changes were observed in mbp expression in Schwann cells myelinating the
lateral line system of the PNS (arrowheads). Dorsal views, anterior is to the top.
Scale bar: 100 μm. (D-E) Bar graphs depicting percentages of embryos with
normal and reduced/absent phenotypes after injection of atx TL MO (D) atx E2I2
MO (E) or respective control MO (D and E). (F) Bar graph depicting the number
of mbp-positive oligodendrocytes in atx TL MO –injected embryos set as a
percentage of control (mean of control = 100%). (G-H) Bar graphs depicting mbp
mRNA levels as percentage of control (mean of control = 100%) for embryos
injected with the atx TL MO (G) and atx E2I2 MO (H). Means ± SEM of five (D),
four (E and F) and three (G and H) independent experiments are shown. Stars
indicate overall two-tailed significance levels of P < 0.05 as determined by
Student’s t-test.
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Figure 4.6. The reduction in the appearance of mbp-positive
oligodendrocytes is not due to a compromised axonal network. Embryos
were injected with either atx TL MO or control MO and staged to 48hpf. (A-D)
Representative examples of embryos stained with an antibody against antiacetylated α-tubulin. Shown are head (A) and trunk (C) of control embryos and
head (B) and trunk (D) of atx TL MO-injected embryos. Images were obtained by
confocal microscopy and represent 2D projections of stacks of 5.7μm optical
sections. A and C: Dorsal views, anterior is to the top, scale bar: 100μm, B and
D: Lateral views, anterior is to the left, scale bar: 100μm.
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Figure 4.7. Reduction of ATX expression leads to a reduction in plp1b and
claudink mRNA levels. Embryos were injected with atx TL MO, atx E2I2 MO or
their respective control MOs and staged to 66hpf. RNA was isolated from pooled
embryos and relative levels of mRNA were determined with qRT-PCR. (A and B)
Bar graphs depicting mRNA levels of plp1b and cldnk in embryos injected with
the atx TL MO (A) and the atx E2I2 MO (B). Data are shown as percent of
control (mean of control = 100%). Means ± SEM of three independent
experiments are shown. Stars indicate overall two-tailed significance levels of P
< 0.05 as determined by Student’s t-test.
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Figure 4.8. Reduction of ATX expression leads to a reduction in the
appearance of olig1-positive oligodendrocytes. Embryos were injected with
atx TL, atx E2I2 MO or their respective control MOs and staged to 66hpf. (A-B)
Representative examples of whole mount in situ hybridizations using mRNA
probes specific for olig1. Representative examples of control (A) and atx TL MO
(B) injected fish are shown. Lateral views, anterior is to the right. Scale bar:
100μm for A and B. (C-D) Bar graphs depicting the number of olig1-positive
oligodendrocytes (C) and olig1 mRNA levels (D) shown in percent of control
(mean of control = 100%) and as determined by qRT-PCR. Means ± SEM of four
(C) and three (D) independent experiments are shown. Stars indicate overall
two-tailed significance levels of P < 0.05 as determined by Student’s t-test.
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CHAPTER 5
Final Conclusions
In order for oligodendrocytes to develop and differentiate properly to
ultimately function in myelination, they must undergo tightly regulated stages of
development. Changes in gene regulation as well as morphological remodeling
must occur in parallel and at the appropriate times. The data presented here, as
well as previous data from our laboratory (Fox et al., 2003; Fox et al., 2004;
Dennis et al., 2008; Nogaroli et al., 2009), support the idea that ATX plays an
important functional role in the developmental program of oligodendrocytes by
regulating both of these processes.
More specifically, recent data presented in chapter two suggest that ATX,
through the production of LPA, is necessary for the expression of mbp and
establishment of membranous structures during later stages of oligodendrocyte
development. Chapter four identified ATX as necessary for the timely
appearance of olig1-positive OPCs, a novel functional role not previously
described. Currently the mechanisms leading to this early stage phenotype are
unknown, but it is clear that ATX is necessary for this process at least during
zebrafish development.
Until now, ATX’s function has not been found associated with early stages
of oligodendrocyte development. OPCs do not express ATX endogenously and it
was therefore assumed that ATX would not be necessary for their development.
The finding that atx is expressed in the cephalic floor plate at the time when
oligodendrocytes are being specified and during their early development, as well
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as the notion that ATX is a secreted protein, led to the hypothesis that it could
regulate early oligodendrocyte development both in the zebrafish and in higher
vertebrates (chapter four and (Bachner et al., 1999; Ohuchi et al., 2007)).
Chapter four identified that the presence of ATX in vivo is necessary for
early stages of oligodendrocyte development before the expression of olig1, one
of the earliest markers used to identify oligodendrocytes in the zebrafish (Li et al.,
2007a; Schebesta and Serluca, 2009). Reduced numbers of olig1-positive
oligodendrocytes could be a result from ATX-mediated regulation of
oligodendrocyte specification, early differentiation or proliferation as described in
more detail in chapter four. However, at this point the mechanisms for this
regulatory role of ATX is unclear as is the contribution of each of ATX’s
functionally characterized domains.
The in vitro data presented in chapter two demonstrate that LPA, a
product of ATX’s lysoPLD domain, can promote the establishment of
membranous structures and based on the data presented in chapters two and
four, it appears likely that ATX, via the generation of LPA, promotes mbp
expression in differentiating oligodendrocytes.
LPA-mediated signaling involves binding to G-protein-coupled receptors,
LPA1-3 in oligodendrocytes as described in chapter one, and can initiate many
different signaling cascades via activation of at least three different Gα proteins:
Gαi, Gαq and Gα12/13 (Swarthout and Walling, 2000; Fukushima and Chun, 2001).
In order to induce cell shape changes, LPA can activate signaling cascades
leading to the activation of the Rho family of GTPases, known for their roles in
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regulating signaling pathways linking the extracellular environment to the
organization of the actin cytoskeleton as well as controlling microtubule dynamics
and other functions (Hall, 1998; Etienne-Manneville and Hall, 2002; Moolenaar et
al., 2004). Rho GTPases are expressed by oligodendrocytes (Liang et al., 2004;
Erschbamer et al., 2005) and more specifically, the Rho GTPase family
members, RhoA and Rac1 have been associated with membrane formation in
oligodendrocytes (Thurnherr et al., 2006; Czopka et al., 2009) indicating that
activation of these Rho GTPases could be activated and responsible for LPAinduced membranous structure formation in our studies. Regulation of mbp
expression, alternately, appears to occur independently of this signaling pathway
(Czopka et al., 2009) suggesting that membrane formation and gene expression
are regulated by different downstream signaling pathways. This strongly argues
in favor of a specific role of signaling through the Rho GTPases in regulating
myelin membrane formation, while it appears marginal with regard to mbp
expression.
LPA-induced increases in mbp mRNA levels could potentially be a result
of activation of the mbp promoter as its activity increases as oligodendrocytes
differentiate in culture (Wei et al., 2005). LPA has been shown to have the
capability for promoter activation in myelinating cells as demonstrated in
Schwann cells, where LPA activates the p0 promoter via multiple signaling
pathways, resulting in its increased expression levels (Li et al., 2003).
In oligodendrocytes, expression and phosphorylation levels of CREB
(cyclic AMP-response element binding protein) are important factors regulating
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their differentiation (Sato-Bigbee and Yu, 1993; Sato-Bigbee et al., 1994), and
different signal transduction systems may regulate CREB activation in
oligodendrocytes (Sato-Bigbee et al., 1999). In particular, application of a cAMP
analogue and subsequent activation of CREB can stimulate expression of mbp in
cell culture (Sato-Bigbee and DeVries, 1996; Afshari et al., 2001). These
increases in mbp expression were observed after 24 hours (Afshari et al., 2001),
much longer than the two hours observed in our in vitro studies, indicating that
LPA may not directly activate CREB. Consistent with this observation, LPA
receptors expressed by oligodendrocytes and in particular LPA1, the major LPA
receptor expressed by myelinating oligodendrocytes, does not signal through Gs
and consequently not signal activate cAMP dependent pathway through adenylyl
cyclase (Swarthout and Walling, 2000; Fukushima and Chun, 2001).
Since LPA may not directly regulate CREB expression, other signaling
pathways could be responsible for the increases in mbp mRNA levels seen in our
studies. p0 expression in Schwann cells is partially regulated by activation of the
MAP (mitogen-activated protein) kinase signaling cascade pathway (Li et al.,
2003), composed of kinases that respond to extracellular stimuli leading to
transcriptional regulation (Cobb, 1999). LPA could therefore utilize this signaling
pathway to induce mbp expression. Data supporting this hypothesis include that
LPA can activate ERK1/2 (extracellular signal-regulated kinase) (unpublished
data and (Stankoff et al., 2002)), a kinase within this pathway, and activation of
the MAP kinase pathway has already been shown to regulate mbp expression in
oligodendrocytes via growth factor stimulation (Du et al., 2006). These data
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suggest that LPA-mediated activation of mbp expression in our experiments
could likely be due to direct signaling through this pathway.
Transcription factors other than CREB can also regulate mbp gene
expression. The mbp promoter region contains binding sites for numerous
transcription factors that are known to be involved in transcriptional control of the
mbp gene. No binding site for CREB has been found (Zhang and Miskimins,
1993) but the cell-specific transcription factors olig1 and sox10 can bind to the
mbp promoter and activate its transcription (Wegner, 2000; Stolt et al., 2002; Wei
et al., 2004; Li et al., 2007a). Our in vivo studies indicated that down-regulation of
ATX resulted in less olig1-positive oligodendrocytes. At the present time, we are
unsure what developmental mechanism is regulating this observation, but ATX
release from the floor plate could potentially regulate the expression of
transcription factors such as olig1 (Lu et al., 2000; Alberta et al., 2001). This
activation could then subsequently increase mbp expression.
We observed no changes in mog or plp mRNA expression upon ATX
down-regulation indicating that ATX may specifically regulate mbp expression.
Interestingly, expression of CREB is not necessary for expression of plp as it is
for mbp (Afshari et al., 2001), further supporting the idea that different myelin
genes may be regulated differently as may be true for LPA-induced gene
expression.
Despite the molecular processes involved, ATX has been shown in this
dissertation to be necessary for regulating both early and late stages of
oligodendrocyte development. These roles in the zebrafish studies looking at
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early differentiation or specification are likely resulting from a paracrine
mechanism of ATX released from the floor plate while the later stages of
differentiation may be from an autocrine source as demonstrated in in vitro
studies from our laboratory (Fox et al., 2003; Fox et al., 2004; Dennis et al.,
2008; Nogaroli et al., 2009). During later stages of oligodendrocyte
differentiation, past the timing of our experiments, we have shown that
oligodendrocytes do express atx at this time, a preferentially autocrine
mechanism may be responsible for promoting further stages of oligodendrocyte
differentiation. Expression of atx in the floor plate disappeared around the time
when expression commenced in oligodendrocytes. The reason for this “switch” in
expression is likely because of the transient state of the floor plate (Altman and
Bayer, 1984) as well as the location of oligodendrocytes during later stages of
development. Oligodendrocytes are first specified adjacent to the floor plate and
as they develop, they migrate throughout the brain and spinal cord (Park et al.,
2002; Kirby et al., 2006; Schebesta and Serluca, 2009) and are no longer in
close proximity to the floor plate. Thus, the expression of atx by
oligodendrocytes, and its subsequent secretion into the local extracellular
environment, may be necessary to further regulate their differentiation, consistent
with our in vitro data (see Fig. 5.1 for hypothesized scheme).
All of the data obtained from our laboratory so far, including the recent
data reported in this dissertation, indicate that ATX may be a major regulator
during the entire process of oligodendrocyte development and not just during the
later stages as previously thought. The potential for ATX-mediated control over
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early and late stages of oligodendrocyte differentiation identify ATX as a potential
therapeutic target for MS. Many MS lesions contain premyelinating
oligodendrocytes which lack the ability to differentiate limiting their capability to
remyelinate (Chang et al., 2002; Kuhlmann et al., 2008). OPCs are also present
and recruited to MS lesions initially but may become depleted over time
(Kuhlmann et al., 2008). ATX could potentially be responsible for both of these
processes as atx expression levels are decreased in MS lesions (Comabella and
Martin, 2007) which could limit differentiation while protein levels are increased in
the cerebrospinal fluid of MS patients (Hammack et al., 2004) which could
specify OPCs. Enhanced proliferation and recruitment of OPCs into myelin
lesions from the subventricular zone has been previously described in response
to demyelination (Nait-Oumesmar et al., 2008) and the presence of elevated ATX
levels adjacent to the subventricular zone could result in the increased
specification of OPCs. ATX, as a regulator of oligodendrocyte development,
could therefore be a crucial molecular player important not only during normal
oligodendrocyte development but also necessary for the presence of OPCs and
differentiation of oligodendrocytes in MS lesions.
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Figure 5.1. Hypothesized scheme relating the source of ATX and its
function. The presence of ATX in the local extracellular environment of
oligodendrocytes is necessary for their proper development. ATX released from
the cephalic floor plate regulates early stages of oligodendrocyte development,
such as specification or early differentiation. When expression of atx disappears
in the cephalic floor plate and OPCs have migrated throughout the brain,
oligodendrocytes must express and secrete ATX in order to further promote their
differentiation during later stages of development.
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